<?xml version="1.0" encoding="utf-8"?>
<iati-activities version="2.03" generated-datetime="2026-11-12T12:45:29+00:00">
  <iati-activity last-updated-datetime="2026-11-12T08:12:17+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-UGA-C-TASO-1</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Supporting Uganda's Response to HIV/AIDS - Uganda (01-Jul-2015-31-Dec-2017)</narrative>
    </title>
    <description type="1">
      <narrative>Uganda, TB/HIV, The AIDS Support Organisation (Uganda) Limited</narrative>
    </description>
    <description type="2">
      <narrative>Goals: An effective and sustainable multi-sectoral HIV/AIDs service delivery system that ensures universal access and coverage of quality, efficient and safe services to the targeted population by 2020; To contribute to the reduction of HIV new infection by 77% by 2025; To improve quality of life of PLHIV and decrease HIV- associated mortality by 70% by 2025; To reduce vulnerability to HIV/AIDs and Mitigation of its impact on PLHIV and other vulnerable groups. Objectives: To increase condom use at high risk sex from 50% to 75%; To increase equitable access to ART by those in need from 50% (2014) to 80% by 2018.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="24" role="2" crs-channel-code="23000">
      <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
    </participating-org>
    <participating-org type="24" role="4" crs-channel-code="23000">
      <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
    </participating-org>
    <other-identifier ref="UGA-C-TASOP01" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="4" />
    <activity-date type="1" iso-date="2015-07-01" />
    <activity-date type="2" iso-date="2015-07-01" />
    <activity-date type="3" iso-date="2017-12-31" />
    <activity-date type="4" iso-date="2017-12-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>Saman Zamani</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>saman.zamani@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="UG" percentage="100">
      <narrative>Uganda</narrative>
    </recipient-country>
    <sector vocabulary="1" code="13040" percentage="50">
      <narrative>TB/HIV</narrative>
    </sector>
    <sector vocabulary="1" code="12263" percentage="50">
      <narrative>TB/HIV</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <transaction ref="84e6f79a-fc98-4994-b30f-889b5182b293">
      <transaction-type code="2" />
      <transaction-date iso-date="2015-07-24" />
      <value currency="USD" value-date="2015-07-24">2818622.00</value>
      <description>
        <narrative>Global Fund commitment to UGA-C-TASOP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c7b341cf-f740-416c-b255-b1c2ec4c554e">
      <transaction-type code="3" />
      <transaction-date iso-date="2015-09-25" />
      <value currency="USD" value-date="2015-09-25">869849.00</value>
      <description>
        <narrative>Global Fund disbursement to UGA-C-TASOP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="8586ce40-6d3d-424d-a216-2aba863d4f6b">
      <transaction-type code="2" />
      <transaction-date iso-date="2016-07-28" />
      <value currency="USD" value-date="2016-07-28">-1948773.00</value>
      <description>
        <narrative>Global Fund commitment to UGA-C-TASOP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="20f59cad-fadd-4dd1-93ff-47e0475780ab">
      <transaction-type code="2" />
      <transaction-date iso-date="2016-07-28" />
      <value currency="USD" value-date="2016-07-28">3392195.00</value>
      <description>
        <narrative>Global Fund commitment to UGA-C-TASOP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="85d2c17c-ac5f-4aff-8961-66112278619e">
      <transaction-type code="3" />
      <transaction-date iso-date="2016-08-02" />
      <value currency="USD" value-date="2016-08-02">806136.00</value>
      <description>
        <narrative>Global Fund disbursement to UGA-C-TASOP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="8413811d-f0ec-47a5-bf97-cbd4a8ba25d8">
      <transaction-type code="3" />
      <transaction-date iso-date="2016-09-22" />
      <value currency="USD" value-date="2016-09-22">1154099.00</value>
      <description>
        <narrative>Global Fund disbursement to UGA-C-TASOP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="943ab896-b3d7-476b-87eb-c5044065953d">
      <transaction-type code="2" />
      <transaction-date iso-date="2017-11-15" />
      <value currency="USD" value-date="2017-11-15">3278422.00</value>
      <description>
        <narrative>Global Fund commitment to UGA-C-TASOP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="98abe5fb-8d20-42f7-9ccb-a2b86e566b57">
      <transaction-type code="2" />
      <transaction-date iso-date="2017-11-15" />
      <value currency="USD" value-date="2017-11-15">-1431960.00</value>
      <description>
        <narrative>Global Fund commitment to UGA-C-TASOP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c2088d81-a62c-47c5-98ad-1af1c1256ddf">
      <transaction-type code="2" />
      <transaction-date iso-date="2017-12-01" />
      <value currency="USD" value-date="2017-12-01">-3278422.00</value>
      <description>
        <narrative>Global Fund commitment to UGA-C-TASOP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="efaed4d5-7330-4a5d-9088-fa7ea42acbb1">
      <transaction-type code="2" />
      <transaction-date iso-date="2017-12-01" />
      <value currency="USD" value-date="2017-12-01">2110843.00</value>
      <description>
        <narrative>Global Fund commitment to UGA-C-TASOP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5d439584-aaca-4b98-87c7-d8105c168848">
      <transaction-type code="2" />
      <transaction-date iso-date="2017-12-05" />
      <value currency="USD" value-date="2017-12-05">1846813.78</value>
      <description>
        <narrative>Global Fund commitment to UGA-C-TASOP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="6cd2072d-56b4-452b-8873-094cea666e85">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-12-05" />
      <value currency="USD" value-date="2017-12-05">2110843.00</value>
      <description>
        <narrative>Global Fund disbursement to UGA-C-TASOP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="cf2b67a0-9cec-468e-a0c3-54d9ffd7e92d">
      <transaction-type code="2" />
      <transaction-date iso-date="2017-12-15" />
      <value currency="USD" value-date="2017-12-15">25000.00</value>
      <description>
        <narrative>Global Fund commitment to UGA-C-TASOP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="47d02b92-debd-4142-b523-4006bedbd96c">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-01-30" />
      <value currency="USD" value-date="2018-01-30">961147.42</value>
      <description>
        <narrative>Global Fund disbursement to UGA-C-TASOP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="efe056f7-7481-4ba4-9c76-fe2183517204">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-01-30" />
      <value currency="USD" value-date="2018-01-30">680591.34</value>
      <description>
        <narrative>Global Fund disbursement to UGA-C-TASOP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="d1cffae5-d466-4355-8978-94d97b144e0b">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-03-22" />
      <value currency="USD" value-date="2018-03-22">37702.64</value>
      <description>
        <narrative>Global Fund disbursement to UGA-C-TASOP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="ac689a90-c404-4621-bcbd-b05694ec4f3d">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-04-18" />
      <value currency="USD" value-date="2018-04-18">-25000.00</value>
      <description>
        <narrative>Global Fund commitment to UGA-C-TASOP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b765f170-b58a-43dd-93bc-d9465baae2dd">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-05-08" />
      <value currency="USD" value-date="2018-05-08">17150.07</value>
      <description>
        <narrative>Global Fund disbursement to UGA-C-TASOP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="36bbcce3-9d90-4313-bd59-b4a3a4454e92">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-07-16" />
      <value currency="USD" value-date="2018-07-16">-31842.00</value>
      <description>
        <narrative>Global Fund commitment to UGA-C-TASOP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="68bace76-12ba-4348-a5cb-5d584672f292">
      <transaction-type code="7" />
      <transaction-date iso-date="2018-07-16" />
      <value currency="USD" value-date="2018-07-16">31842.00</value>
      <description>
        <narrative>Funds returned to the Global Fund from UGA-C-TASOP01.</narrative>
      </description>
      <provider-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d9f74785-0567-4178-b381-97ef3e1c8ab3">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-07-23" />
      <value currency="USD" value-date="2018-07-23">163248.96</value>
      <description>
        <narrative>Global Fund commitment to UGA-C-TASOP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="db3b5860-5757-4c15-b07e-4635237ec2a4">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-07-23" />
      <value currency="USD" value-date="2018-07-23">-150222.31</value>
      <description>
        <narrative>Global Fund commitment to UGA-C-TASOP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="9b8742c2-16dc-4614-b4b1-223c9c7295ac">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-07-23" />
      <value currency="USD" value-date="2018-07-23">-13026.65</value>
      <description>
        <narrative>Global Fund commitment to UGA-C-TASOP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5eb48a7f-b545-40e7-9e8a-69b46ebddd36">
      <transaction-type code="7" />
      <transaction-date iso-date="2018-07-27" />
      <value currency="USD" value-date="2018-07-27">13026.65</value>
      <description>
        <narrative>Funds returned to the Global Fund from UGA-C-TASOP01.</narrative>
      </description>
      <provider-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a7fa191b-d0ac-470a-ae66-5b6fcf44e907">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-09-30" />
      <value currency="USD" value-date="2018-09-30">-163248.96</value>
      <description>
        <narrative>Global Fund commitment to UGA-C-TASOP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="3ef09668-d908-4958-8efc-dbf9cf67a2bf">
      <transaction-type code="7" />
      <transaction-date iso-date="2019-12-23" />
      <value currency="USD" value-date="2019-12-23">20582.00</value>
      <description>
        <narrative>Funds returned to the Global Fund from UGA-C-TASOP01.</narrative>
      </description>
      <provider-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="607b2086-b91a-49e0-8751-588486026a84">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-01-02" />
      <value currency="USD" value-date="2020-01-02">-20582.00</value>
      <description>
        <narrative>Global Fund commitment to UGA-C-TASOP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="40fc618f-1a51-41c5-87ba-878032885e6e">
      <transaction-type code="7" />
      <transaction-date iso-date="2020-11-13" />
      <value currency="USD" value-date="2020-11-13">9016.00</value>
      <description>
        <narrative>Funds returned to the Global Fund from UGA-C-TASOP01.</narrative>
      </description>
      <provider-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d09da972-748c-4da6-a7f3-7e3e388dd861">
      <transaction-type code="7" />
      <transaction-date iso-date="2020-11-13" />
      <value currency="USD" value-date="2020-11-13">325466.80</value>
      <description>
        <narrative>Funds returned to the Global Fund from UGA-C-TASOP01.</narrative>
      </description>
      <provider-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f603bec2-302d-4623-9602-1734aa2df65a">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-11-27" />
      <value currency="USD" value-date="2020-11-27">-9016.00</value>
      <description>
        <narrative>Global Fund commitment to UGA-C-TASOP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="11901138-a2e8-48bd-bfcf-2fc958597931">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-11-27" />
      <value currency="USD" value-date="2020-11-27">-325466.80</value>
      <description>
        <narrative>Global Fund commitment to UGA-C-TASOP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="3e2d1092-a56f-4c35-a363-027495b9acd1">
      <transaction-type code="7" />
      <transaction-date iso-date="2023-02-06" />
      <value currency="USD" value-date="2023-02-06">14672.00</value>
      <description>
        <narrative>Funds returned to the Global Fund from UGA-C-TASOP01.</narrative>
      </description>
      <provider-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="1e73b76b-4268-4e89-8a83-7582cae66d6a">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-02-17" />
      <value currency="USD" value-date="2023-02-17">-14672.00</value>
      <description>
        <narrative>Global Fund commitment to UGA-C-TASOP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/UGA-C-TASO" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-12" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of sex workers reached with HIV prevention programs - defined package of services</narrative>
      </title>
      <description>
        <narrative>Module: Comprehensive prevention programs for sex workers and their clients.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of sex workers reached with HIV prevention programs - defined package of services</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2014" iso-date="2014-12-31">
          <comment>
            <narrative>Numerator: 15059; Denominator: 54549; Percentage: 27.6%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2015-07-01" />
          <period-end iso-date="2015-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 3849.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 7698.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 7698.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 16859.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 14134.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 10039.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 14134.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 17678.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of MSM reached with HIV prevention programs - defined package of services</narrative>
      </title>
      <description>
        <narrative>Module: Prevention programs for MSM and TGs.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of MSM reached with HIV prevention programs - defined package of services</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2014" iso-date="2014-12-31">
          <comment>
            <narrative>Numerator: 427; Denominator: 10533; Percentage: 4.1%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2015-07-01" />
          <period-end iso-date="2015-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 536.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 928.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 928.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 349.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 2256.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 873.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2256.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2333.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
  </iati-activity>
  <iati-activity last-updated-datetime="2026-11-12T08:12:17+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-UGA-C-TASO-2</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Supporting Uganda’s Response to the HIV/AIDS and Tuberculosis Reduction Strategy - Uganda (01-Jan-2018-31-Dec-2020)</narrative>
    </title>
    <description type="1">
      <narrative>Uganda, TB/HIV, The AIDS Support Organisation (Uganda) Limited</narrative>
    </description>
    <description type="2">
      <narrative>Goals: To reduce the number of new youth and adult infections by 70% and the number of new paediatric HIV infections by 95% by 2020; To decrease HIV-associated morbidity and mortality by 70% through achieving and maintaining 90% viral suppression by 2020; To reduce vulnerability to HIV/AIDS and mitigation of its impact on PLHIV and other vulnerable groups; The goal is to reduce the incidence by 5% by 2019/20: from 234/100,000 in 2015/16 to 222.3/100,000 by 2019/20. Objectives: To increase equitable access to ART by  those in need from 64% (2016) to 81% by 2020; To increase condom use at  high risk sex from 50% to 75% by 2020; To increase case notification rate of incident TB cases from 119/100,000 in 2015/16 to 156/100,00 in 2019/20; and to increase treatment success rate among notified incident cases from 74% in 2015/26 to 85% by 2019/20;; To strengthen TB-HIV integrated care for co-infected patients and increase ART coverage among TB/HIV co-infected patients from 88% in 2015/16 to 95% by 2019/20; To increase CDR DR-TB from 17% in 2015/16 to 51% in 2019/20; and raise TSR from 74% in 2015/16 to 80% by 2019/20; To strengthen systems for effective management of Tuberculosis &amp; Leprosy services to meet the NSP targets.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="24" role="2" crs-channel-code="23000">
      <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
    </participating-org>
    <participating-org type="24" role="4" crs-channel-code="23000">
      <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
    </participating-org>
    <other-identifier ref="UGA-C-TASOP02" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="4" />
    <activity-date type="1" iso-date="2018-01-01" />
    <activity-date type="2" iso-date="2018-01-01" />
    <activity-date type="3" iso-date="2020-12-31" />
    <activity-date type="4" iso-date="2020-12-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>Saman Zamani</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>saman.zamani@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="UG" percentage="100">
      <narrative>Uganda</narrative>
    </recipient-country>
    <sector vocabulary="1" code="13040" percentage="67.85">
      <narrative>HIV</narrative>
    </sector>
    <sector vocabulary="1" code="12263" percentage="20.57">
      <narrative>Tuberculosis</narrative>
    </sector>
    <sector vocabulary="1" code="12110" percentage="11.58">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="43040121-7c59-4d93-9b1a-708f68d30073" percentage="0.58">
        <description>
          <narrative>HIV -&gt; PMTCT -&gt; Prong 1: Primary prevention of HIV infection among women of childbearing age</narrative>
        </description>
      </budget-item>
      <budget-item code="02835168-3d6f-499f-b99f-10c2ddee5f1c" percentage="0.69">
        <description>
          <narrative>HIV -&gt; Prevention programs for adolescents and youth, in and out of school -&gt; Addressing stigma, discrimination and legal barriers to care for adolescents and youth</narrative>
        </description>
      </budget-item>
      <budget-item code="a043623f-0c87-42d4-8d1a-14144145ecb6" percentage="7.06">
        <description>
          <narrative>HIV -&gt; Prevention programs for adolescents and youth, in and out of school -&gt; Behavioral change as part of programs for adolescent and youth</narrative>
        </description>
      </budget-item>
      <budget-item code="c720b257-8368-4aff-acdb-5fc2ba3b9530" percentage="2.68">
        <description>
          <narrative>HIV -&gt; Prevention programs for adolescents and youth, in and out of school -&gt; Community mobilization and norms change</narrative>
        </description>
      </budget-item>
      <budget-item code="7460fcfb-c606-41d9-ab9e-e457af0710fd" percentage="1.5">
        <description>
          <narrative>HIV -&gt; Prevention programs for adolescents and youth, in and out of school -&gt; Gender-based violence prevention and treatment programs for adolescents and youth</narrative>
        </description>
      </budget-item>
      <budget-item code="6dbca3a1-2166-42e6-89a3-dccb7ecfcb04" percentage="20.56">
        <description>
          <narrative>HIV -&gt; Prevention programs for adolescents and youth, in and out of school -&gt; Keeping girls in school</narrative>
        </description>
      </budget-item>
      <budget-item code="9548700f-d4e0-4aa8-b1f6-ebd43a163444" percentage="0.1">
        <description>
          <narrative>HIV -&gt; Prevention programs for adolescents and youth, in and out of school -&gt; Other intervention(s) for adolescent and youth</narrative>
        </description>
      </budget-item>
      <budget-item code="bacec71a-3986-414a-b135-8dd9b691c25a" percentage="3.3">
        <description>
          <narrative>HIV -&gt; Prevention programs for adolescents and youth, in and out of school -&gt; Socioeconomic approaches</narrative>
        </description>
      </budget-item>
      <budget-item code="4f37aa99-df46-4259-b8fb-1041649f9a9e" percentage="0.82">
        <description>
          <narrative>HIV -&gt; Prevention programs for general population -&gt; Condoms as part of programs for general population</narrative>
        </description>
      </budget-item>
      <budget-item code="f656ae4a-0f86-4a63-bf7a-8dce1eda4edd" percentage="2.55">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; HIV and HIV/TB-related legal services</narrative>
        </description>
      </budget-item>
      <budget-item code="557c641d-d721-482b-a47f-096caa882957" percentage="1.64">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Human rights and medical ethics related to HIV and HIV/TB for health care providers</narrative>
        </description>
      </budget-item>
      <budget-item code="58c0b914-97aa-48f7-a852-b18c3835a345" percentage="2.2">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Improving laws, regulations and policies relating to HIV and HIV/TB</narrative>
        </description>
      </budget-item>
      <budget-item code="dd23042c-9916-42f5-9c9c-f89101c2bb28" percentage="0.22">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Legal literacy ("Know Your Rights" campaign)</narrative>
        </description>
      </budget-item>
      <budget-item code="eb5dd4fc-28e5-4757-a299-6f65a79864b6" percentage="19.57">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Other intervention(s) to reduce human rights-related barriers to HIV services</narrative>
        </description>
      </budget-item>
      <budget-item code="9be4808c-abeb-454c-a395-bb31509c67b1" percentage="1.75">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Reducing HIV-related gender discrimination, harmful gender norms and violence against women and girls in all their diversity</narrative>
        </description>
      </budget-item>
      <budget-item code="48484293-8d88-4a4d-ac0d-6ea012152220" percentage="0.79">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Sensitization of law-makers and law-enforcement agents</narrative>
        </description>
      </budget-item>
      <budget-item code="27cc825e-cdd6-4725-8a33-53f5a933b287" percentage="1.35">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Stigma and discrimination reduction (HIV/TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="e53ba535-c657-45be-8818-ca510aadaba3" percentage="0.48">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; Other intervention(s) for treatment</narrative>
        </description>
      </budget-item>
      <budget-item code="c7d050d8-ddb8-42db-a948-04038ae9cd0f" percentage="0.01">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; Treatment monitoring - Viral load</narrative>
        </description>
      </budget-item>
      <budget-item code="e07bbbe4-54fa-4084-a6fe-7f1c9c3b77b6" percentage="9.18">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="ccf25cc9-a86c-4849-a5ee-61fcfbc7eb36" percentage="0.3">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Community-based monitoring</narrative>
        </description>
      </budget-item>
      <budget-item code="4cd90b50-0924-481f-b5a1-22b7305b5dbb" percentage="1.26">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Community-led research and advocacy</narrative>
        </description>
      </budget-item>
      <budget-item code="04ad0584-b1dd-4ef6-ac1e-dad3669a97d1" percentage="0.61">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Institutional capacity building, planning and leadership development</narrative>
        </description>
      </budget-item>
      <budget-item code="2c00622f-0877-4553-993e-389582dbbfd1" percentage="0.24">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Social mobilization, building community linkages and coordination</narrative>
        </description>
      </budget-item>
      <budget-item code="1c7b99cb-f18c-499f-a55d-f7a0d6b99b21" percentage="0.21">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Case detection and diagnosis (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="5e616c4b-3854-4008-8caa-4cb786ae6fe1" percentage="2.46">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Engaging all care providers (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="8bfd5db3-426b-4dc3-aec1-929f85b850a4" percentage="17.26">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Other MDR-TB intervention(s)</narrative>
        </description>
      </budget-item>
      <budget-item code="f7014493-22e9-4c03-96d0-144fbb3a254f" percentage="0.5">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Case detection and diagnosis (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="13c1e439-070b-4238-9903-7972703a027e" percentage="0.13">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; Collaborative activities with other programs and sectors (TB/HIV)</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2018-01-01" />
      <period-end iso-date="2018-12-31" />
      <value currency="USD" value-date="2018-01-01">2002183.93</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2019-01-01" />
      <period-end iso-date="2019-12-31" />
      <value currency="USD" value-date="2019-01-01">7521655.15</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2020-01-01" />
      <period-end iso-date="2020-12-31" />
      <value currency="USD" value-date="2020-01-01">11552394.68</value>
    </budget>
    <capital-spend percentage="2.28" />
    <transaction ref="0e222ed4-4a61-4404-92f6-98309e2d5d6a">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-01-17" />
      <value currency="USD" value-date="2018-01-17">7592802.79</value>
      <description>
        <narrative>Global Fund commitment to UGA-C-TASOP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="9f4ce66e-4b7e-4354-b932-3d5fec1231e6">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-01-18" />
      <value currency="USD" value-date="2018-01-18">623253.96</value>
      <description>
        <narrative>Global Fund disbursement to UGA-C-TASOP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="9b31e325-ce8d-4395-a646-373180a84de1">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-06-07" />
      <value currency="USD" value-date="2018-06-07">10239112.27</value>
      <description>
        <narrative>Global Fund commitment to UGA-C-TASOP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="7962612b-9e53-40fa-b33f-4a8f119aa1d8">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-06-07" />
      <value currency="USD" value-date="2018-06-07">-6969548.83</value>
      <description>
        <narrative>Global Fund commitment to UGA-C-TASOP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f2e98bfe-f589-44a0-be80-7ff1d326163b">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-06-08" />
      <value currency="USD" value-date="2018-06-08">1303834.01</value>
      <description>
        <narrative>Global Fund disbursement to UGA-C-TASOP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="cf161e99-cb24-42ce-af32-00387fefecad">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-10-16" />
      <value currency="USD" value-date="2018-10-16">4514956.95</value>
      <description>
        <narrative>Global Fund disbursement to UGA-C-TASOP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="7b53ca14-3b77-487b-920c-b4e0eea61b11">
      <transaction-type code="2" />
      <transaction-date iso-date="2019-06-21" />
      <value currency="USD" value-date="2019-06-21">59261.43</value>
      <description>
        <narrative>Global Fund commitment to UGA-C-TASOP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d7a7ae28-d872-40b3-b552-5970646d110c">
      <transaction-type code="2" />
      <transaction-date iso-date="2019-07-03" />
      <value currency="USD" value-date="2019-07-03">11446050.90</value>
      <description>
        <narrative>Global Fund commitment to UGA-C-TASOP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="687451e1-e4a0-4c7b-aa53-b712887f3952">
      <transaction-type code="2" />
      <transaction-date iso-date="2019-07-03" />
      <value currency="USD" value-date="2019-07-03">-4420321.31</value>
      <description>
        <narrative>Global Fund commitment to UGA-C-TASOP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="8e26e50b-82e6-46cf-9505-332424e9c241">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-07-04" />
      <value currency="USD" value-date="2019-07-04">3354445.90</value>
      <description>
        <narrative>Global Fund disbursement to UGA-C-TASOP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="9f67cbb0-01f2-410b-a96d-c19aa7c4a763">
      <transaction-type code="2" />
      <transaction-date iso-date="2019-07-23" />
      <value currency="USD" value-date="2019-07-23">-59261.43</value>
      <description>
        <narrative>Global Fund commitment to UGA-C-TASOP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="3edb26c9-be7c-4903-92ef-1763b87f01bb">
      <transaction-type code="2" />
      <transaction-date iso-date="2019-07-23" />
      <value currency="USD" value-date="2019-07-23">72935.92</value>
      <description>
        <narrative>Global Fund commitment to UGA-C-TASOP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="49d2d6b8-9de5-4e63-a4e7-da7704ec69d4">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-11-01" />
      <value currency="USD" value-date="2019-11-01">2177172.43</value>
      <description>
        <narrative>Global Fund disbursement to UGA-C-TASOP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="b8b068d0-1f49-4894-b9c9-22c4fe3c0d8e">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-12-12" />
      <value currency="USD" value-date="2019-12-12">13446.40</value>
      <description>
        <narrative>Global Fund disbursement to UGA-C-TASOP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="d6fd9652-3216-4621-ad75-74c2b78855e5">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-12-12" />
      <value currency="USD" value-date="2019-12-12">59261.43</value>
      <description>
        <narrative>Global Fund disbursement to UGA-C-TASOP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="832870ca-a4d0-448e-9f68-71ce1e553e33">
      <transaction-type code="2" />
      <transaction-date iso-date="2019-12-13" />
      <value currency="USD" value-date="2019-12-13">5204.76</value>
      <description>
        <narrative>Global Fund commitment to UGA-C-TASOP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="bd53b807-e125-48bf-9b91-a9ba390bc0c8">
      <transaction-type code="2" />
      <transaction-date iso-date="2019-12-13" />
      <value currency="USD" value-date="2019-12-13">-4976.67</value>
      <description>
        <narrative>Global Fund commitment to UGA-C-TASOP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="0a3a6d82-ebe6-42fc-b53a-0197810b9844">
      <transaction-type code="2" />
      <transaction-date iso-date="2019-12-13" />
      <value currency="USD" value-date="2019-12-13">-228.09</value>
      <description>
        <narrative>Global Fund commitment to UGA-C-TASOP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="459e3c48-9276-464c-b8cd-795ddd9ea81c">
      <transaction-type code="7" />
      <transaction-date iso-date="2019-12-17" />
      <value currency="USD" value-date="2019-12-17">4976.67</value>
      <description>
        <narrative>Funds returned to the Global Fund from UGA-C-TASOP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="99ee9959-6ae0-4f81-9db4-cd05124cd91e">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-01-23" />
      <value currency="USD" value-date="2020-01-23">51792.80</value>
      <description>
        <narrative>Global Fund commitment to UGA-C-TASOP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5ebd503b-8a47-4adf-a6c5-61374e0548ff">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-01-28" />
      <value currency="USD" value-date="2020-01-28">51792.80</value>
      <description>
        <narrative>Global Fund disbursement to UGA-C-TASOP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="1994c042-b819-4a2d-9818-1af5e860677d">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-02-04" />
      <value currency="USD" value-date="2020-02-04">3488233.00</value>
      <description>
        <narrative>Global Fund disbursement to UGA-C-TASOP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="cf62f929-5015-4158-96d0-9e1d94990955">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-03-18" />
      <value currency="USD" value-date="2020-03-18">-5204.76</value>
      <description>
        <narrative>Global Fund commitment to UGA-C-TASOP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ea77fcf3-c670-41af-bc63-ccbdfadcca5d">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-08-26" />
      <value currency="USD" value-date="2020-08-26">5139491.00</value>
      <description>
        <narrative>Global Fund commitment to UGA-C-TASOP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ef5c30c6-4bba-4378-a6d5-9c5a6cd0f1c9">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-08-26" />
      <value currency="USD" value-date="2020-08-26">-2426199.57</value>
      <description>
        <narrative>Global Fund commitment to UGA-C-TASOP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="65f24c5b-5642-41e1-80a6-b37bd6693258">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-09-02" />
      <value currency="USD" value-date="2020-09-02">3869075.00</value>
      <description>
        <narrative>Global Fund disbursement to UGA-C-TASOP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="19539d8b-eaf9-4b81-9169-773d9ca08c3a">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-03-19" />
      <value currency="USD" value-date="2021-03-19">543595.00</value>
      <description>
        <narrative>Global Fund disbursement to UGA-C-TASOP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="8fd3f951-56ab-433f-87d3-4078532c7da3">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-04-09" />
      <value currency="USD" value-date="2021-04-09">195192.00</value>
      <description>
        <narrative>Global Fund disbursement to UGA-C-TASOP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="6bd6e894-d83c-4508-905a-a3c729af52fa">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-10-05" />
      <value currency="USD" value-date="2022-10-05">-531629.00</value>
      <description>
        <narrative>Global Fund commitment to UGA-C-TASOP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="UGA-C-TASOP02-EXP-20181231">
      <transaction-type code="4" />
      <transaction-date iso-date="2018-12-31" />
      <value currency="USD" value-date="2018-12-31">1914082.35</value>
      <description>
        <narrative>Expenditure reported by The AIDS Support Organisation (Uganda) Limited for UGA-C-TASOP02, Jan 2018 to Dec 2018.</narrative>
      </description>
      <provider-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </provider-org>
    </transaction>
    <transaction ref="UGA-C-TASOP02-EXP-20191231">
      <transaction-type code="4" />
      <transaction-date iso-date="2019-12-31" />
      <value currency="USD" value-date="2019-12-31">5865857.27</value>
      <description>
        <narrative>Expenditure reported by The AIDS Support Organisation (Uganda) Limited for UGA-C-TASOP02, Jan 2019 to Dec 2019.</narrative>
      </description>
      <provider-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </provider-org>
    </transaction>
    <transaction ref="UGA-C-TASOP02-EXP-20201231">
      <transaction-type code="4" />
      <transaction-date iso-date="2020-12-31" />
      <value currency="USD" value-date="2020-12-31">10762902.00</value>
      <description>
        <narrative>Expenditure reported by The AIDS Support Organisation (Uganda) Limited for UGA-C-TASOP02, Jan 2020 to Dec 2020.</narrative>
      </description>
      <provider-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </provider-org>
    </transaction>
    <transaction ref="UGA-C-TASOP02-EXP-20210630">
      <transaction-type code="4" />
      <transaction-date iso-date="2021-06-30" />
      <value currency="USD" value-date="2021-06-30">1368073.14</value>
      <description>
        <narrative>Expenditure reported by The AIDS Support Organisation (Uganda) Limited for UGA-C-TASOP02, Jan 2021 to Jun 2021.</narrative>
      </description>
      <provider-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/UGA-C-TASO" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-12" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of men who have sex with men reached with HIV prevention programs - defined package of services</narrative>
      </title>
      <description>
        <narrative>Module: Comprehensive prevention programs for MSM.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of men who have sex with men reached with HIV prevention programs - defined package of services</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31">
          <comment>
            <narrative>Numerator: 349.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1800.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 0; Percentage: 0%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2160.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 603.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 2592.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1351.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2851.2.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 4938.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 3136.32.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1863.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 3449.95.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 5680.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of men who have sex with men that have received an HIV test during the reporting period and know their results</narrative>
      </title>
      <description>
        <narrative>Module: Comprehensive prevention programs for MSM.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Percentage of men who have sex with men that have received an HIV test during the reporting period and know their results</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31" value="305" />
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="1620" />
          <actual value="0" />
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="1944" />
          <actual value="2121" />
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="2332.8" />
          <actual value="3433" />
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="2566.08" />
          <actual value="4938" />
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="2822.69" />
          <actual value="1863" />
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="3104.96" />
          <actual value="6109" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of sex workers reached with HIV prevention programs - defined package of services</narrative>
      </title>
      <description>
        <narrative>Module: Comprehensive prevention programs for sex workers and their clients.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Percentage of sex workers reached with HIV prevention programs - defined package of services</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31" value="16265" />
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="6480" />
          <actual value="0" />
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="7452" />
          <actual value="5000" />
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="8569.8" />
          <actual value="5091" />
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="9855.27" />
          <actual value="17094" />
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="10249.48" />
          <actual value="13462" />
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="10659.46" />
          <actual value="14559" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of sex workers that have received an HIV test during the reporting period and know their results</narrative>
      </title>
      <description>
        <narrative>Module: Comprehensive prevention programs for sex workers and their clients.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Percentage of sex workers that have received an HIV test during the reporting period and know their results</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31" value="15734" />
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="5832" />
          <actual value="0" />
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="6998.4" />
          <actual value="12435" />
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="8398.08" />
          <actual value="20531" />
        </period>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="10077.7" />
          <actual value="17094" />
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="11085.47" />
          <actual value="13462" />
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="12194.01" />
          <actual value="15565" />
        </period>
      </indicator>
    </result>
  </iati-activity>
  <iati-activity last-updated-datetime="2026-11-12T12:45:29+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-UGA-C-TASO-3</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Supporting Uganda’s Response to HIV/AIDS and Tuberculosis Reduction Strategy - Uganda (01-Jan-2021-31-Dec-2023)</narrative>
    </title>
    <description type="1">
      <narrative>Uganda, TB/HIV, The AIDS Support Organisation (Uganda) Limited</narrative>
    </description>
    <description type="2">
      <narrative>Goals: Increase productivity, inclusiveness and wellbeing of population through ending HIV and AIDS as an epidemic by 2030; To reduce the incidence of TB from 200/100,000 to 160/100,000 by 2024/25. Objectives: To reduce the number of youth and adult HIV infections by 65% and paediatric HIV infections by 95% by 2025; To reduce HIV related morbidity and mortality and contribute to preventing new HIV infections by 2025; To strengthen social and economic protection to reduce vulnerability to HIV and AIDS and mitigation of its impact on PLHIV, OVC, key populations and other vulnerable groups; To strengthen the multi-sectoral HIV and AIDS service delivery system that ensures sustainable access of efficient and quality services to all targeted populations; To strengthen the national HIV and AIDS strategic information management system for improved effectiveness and efficiency; To create awareness about TB and increase the proportion of people with TB symptoms that seek appropriate care from health facilities from 61% to 90% by 2024/2025; To increase TB preventive treatment coverage among eligible people to &gt;90% by 2024/25; To increase TB treatment coverage from 76% in 2019 to &gt;90% by 2024/25; To increase TSR from 72% in 2019 to &gt;90% by 2024/25; To build effective and efficient systems that ensure quality, equitable and timely TB and Leprosy services.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="24" role="2" crs-channel-code="23000">
      <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
    </participating-org>
    <participating-org type="24" role="4" crs-channel-code="23000">
      <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
    </participating-org>
    <other-identifier ref="UGA-C-TASOP03" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="3" />
    <activity-date type="1" iso-date="2021-01-01" />
    <activity-date type="2" iso-date="2021-01-01" />
    <activity-date type="3" iso-date="2023-12-31" />
    <activity-date type="4" iso-date="2023-12-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>Saman Zamani</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>saman.zamani@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="UG" percentage="100">
      <narrative>Uganda</narrative>
    </recipient-country>
    <sector vocabulary="1" code="13040" percentage="56.34">
      <narrative>HIV</narrative>
    </sector>
    <sector vocabulary="1" code="12110" percentage="26.7">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <sector vocabulary="1" code="12263" percentage="16.96">
      <narrative>Tuberculosis</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="67b7abf2-42e5-4cc4-b75d-4eb6ea4f22b4" percentage="1.48">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Self-testing</narrative>
        </description>
      </budget-item>
      <budget-item code="8cc23209-2129-4c18-b058-a4c3a63b6ae4" percentage="0.1">
        <description>
          <narrative>HIV -&gt; PMTCT -&gt; Prong 3: Preventing vertical HIV transmission</narrative>
        </description>
      </budget-item>
      <budget-item code="88657fe2-2942-4159-860a-af9e84e64238" percentage="9.64">
        <description>
          <narrative>HIV -&gt; Prevention -&gt; Behavior change interventions</narrative>
        </description>
      </budget-item>
      <budget-item code="e60fdd71-5159-45b8-b0e5-887e3c84eba3" percentage="23.14">
        <description>
          <narrative>HIV -&gt; Prevention -&gt; Community empowerment</narrative>
        </description>
      </budget-item>
      <budget-item code="b0f7e056-b292-405c-81ee-0e3d059dde00" percentage="1.11">
        <description>
          <narrative>HIV -&gt; Prevention -&gt; Condom and lubricant programming</narrative>
        </description>
      </budget-item>
      <budget-item code="dca7e9d2-7860-49a4-8fb9-9fe629cd8d8c" percentage="3.18">
        <description>
          <narrative>HIV -&gt; Prevention -&gt; Interventions for young key populations</narrative>
        </description>
      </budget-item>
      <budget-item code="06f7d2bb-99d8-4c7b-95d2-bc02c0b90b93" percentage="0.6">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Community mobilization and advocacy (HIV/TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="56595a18-f1ed-4f39-8c05-d687d5911e6b" percentage="2.14">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Human rights and medical ethics related to HIV and HIV/TB for health care providers</narrative>
        </description>
      </budget-item>
      <budget-item code="0d76926d-3ff4-4be9-b57c-a4cbfd9a134f" percentage="2.44">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Improving laws, regulations and policies relating to HIV and HIV/TB</narrative>
        </description>
      </budget-item>
      <budget-item code="fe7b40b4-5c8d-41e2-b78b-e98fa68cabe7" percentage="5.23">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Legal literacy ("Know Your Rights" campaign)</narrative>
        </description>
      </budget-item>
      <budget-item code="1f63d5bb-7cf1-4ecd-a1a0-6f951b7f88a7" percentage="4.75">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Sensitization of law-makers and law-enforcement agents</narrative>
        </description>
      </budget-item>
      <budget-item code="9476a49e-917c-4607-b0d3-5ccee13653a6" percentage="2.53">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Stigma and discrimination reduction (HIV/TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="6a7cb452-4c5d-49b6-aa43-8437d24fa1c5" percentage="1.75">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Coordination and management of national disease control programs</narrative>
        </description>
      </budget-item>
      <budget-item code="31a8e187-9648-42f5-a520-92e7e53d4ac6" percentage="7">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="a459608e-6d6a-4392-8e91-a6ce763883ca" percentage="5.03">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Community-based monitoring</narrative>
        </description>
      </budget-item>
      <budget-item code="792f3049-9f2b-41ae-a2df-af58779797ea" percentage="3.55">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Community-led research and advocacy</narrative>
        </description>
      </budget-item>
      <budget-item code="e61e1ae8-85c6-488f-8a92-215981bf93a2" percentage="9.37">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Social mobilization, building community linkages and coordination</narrative>
        </description>
      </budget-item>
      <budget-item code="30f85a5d-1110-4276-932f-a742fc65c90f" percentage="0.07">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Case detection and diagnosis (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="8194063f-1bf8-4be2-9ebd-2823d5ac44a3" percentage="10.17">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Treatment (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="e5d69248-af9e-44de-a99d-c2557c675f55" percentage="0.07">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Engaging all care providers (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="3ec9daf3-963a-4853-8e5f-65867d3e7630" percentage="6.38">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Prevention (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="2b47e4dd-6430-4bc5-829c-127bb93a72a8" percentage="0.27">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Treatment (TB care and prevention)</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2021-01-01" />
      <period-end iso-date="2021-12-31" />
      <value currency="USD" value-date="2021-01-01">18040029.58</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2022-01-01" />
      <period-end iso-date="2022-12-31" />
      <value currency="USD" value-date="2022-01-01">11354958.87</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2023-01-01" />
      <period-end iso-date="2023-12-31" />
      <value currency="USD" value-date="2023-01-01">8005230.91</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2024-01-01" />
      <period-end iso-date="2024-12-31" />
      <value currency="USD" value-date="2024-01-01">5958948.39</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2025-01-01" />
      <period-end iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-01-01">887772.59</value>
    </budget>
    <capital-spend percentage="5.22" />
    <transaction ref="66f5fbbb-b83d-47a0-8695-6428fdd53807">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-12-18" />
      <value currency="USD" value-date="2020-12-18">23305431.34</value>
      <description>
        <narrative>Global Fund commitment to UGA-C-TASOP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ea8a42c4-3a28-4ea0-8dc9-eb897f93d5d4">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-01-20" />
      <value currency="USD" value-date="2021-01-20">6900161.00</value>
      <description>
        <narrative>Global Fund disbursement to UGA-C-TASOP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="7d9bffb6-ad5e-467b-8af0-7c2cfa67b412">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-04-24" />
      <value currency="USD" value-date="2021-04-24">49375.28</value>
      <description>
        <narrative>Global Fund commitment to UGA-C-TASOP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="65c2f321-1917-4cac-a0f0-91597f6a6b15">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-04-27" />
      <value currency="USD" value-date="2021-04-27">49375.28</value>
      <description>
        <narrative>Global Fund disbursement to UGA-C-TASOP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="ce0502d3-0f44-45ba-97ff-a5b12f0bc551">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-06-10" />
      <value currency="USD" value-date="2021-06-10">40248.82</value>
      <description>
        <narrative>Global Fund commitment to UGA-C-TASOP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="814ddb6f-88f0-43b1-abe3-e5a6c5617331">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-08-18" />
      <value currency="USD" value-date="2021-08-18">40248.82</value>
      <description>
        <narrative>Global Fund disbursement to UGA-C-TASOP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="f3c9d48c-1526-4851-9f91-2379f6557e22">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-09-16" />
      <value currency="USD" value-date="2021-09-16">3897087.00</value>
      <description>
        <narrative>Global Fund disbursement to UGA-C-TASOP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c58d6cd0-0b0c-4dc8-8402-7367c9a5294b">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-11-30" />
      <value currency="USD" value-date="2021-11-30">47132.87</value>
      <description>
        <narrative>Global Fund commitment to UGA-C-TASOP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="e895b152-2271-434a-8b47-faa831997f1b">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-12-02" />
      <value currency="USD" value-date="2021-12-02">47132.87</value>
      <description>
        <narrative>Global Fund disbursement to UGA-C-TASOP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="e7012c3f-276f-4581-b39b-8da02a471d1d">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-04-28" />
      <value currency="USD" value-date="2022-04-28">4150974.00</value>
      <description>
        <narrative>Global Fund disbursement to UGA-C-TASOP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="8da79eb6-7704-41e3-ae07-5465dae87cb0">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-05-19" />
      <value currency="USD" value-date="2022-05-19">416144.87</value>
      <description>
        <narrative>Global Fund disbursement to UGA-C-TASOP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="2ccb4bb1-4c4a-4de9-8ce0-2ac80c0a4ba4">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-05-30" />
      <value currency="USD" value-date="2022-05-30">862893.00</value>
      <description>
        <narrative>Global Fund disbursement to UGA-C-TASOP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="27eb3838-9091-49b1-8eb5-45aaae1c8a0d">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-06-23" />
      <value currency="USD" value-date="2022-06-23">744853.00</value>
      <description>
        <narrative>Global Fund disbursement to UGA-C-TASOP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="591a330a-c2da-4008-a9f7-756c5e40ac47">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-08-03" />
      <value currency="USD" value-date="2022-08-03">4214.89</value>
      <description>
        <narrative>Global Fund commitment to UGA-C-TASOP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="1551ca2b-7f0b-4a6b-a6cf-f240aae3ab03">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-09-03" />
      <value currency="USD" value-date="2022-09-03">-4214.89</value>
      <description>
        <narrative>Global Fund commitment to UGA-C-TASOP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="638522bf-5f3c-4278-91a6-411946cb6f60">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-09-03" />
      <value currency="USD" value-date="2022-09-03">8834.57</value>
      <description>
        <narrative>Global Fund commitment to UGA-C-TASOP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="64566bfe-996f-4c1f-8d3d-6b2c32a84da8">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-09-03" />
      <value currency="USD" value-date="2022-09-03">-4619.68</value>
      <description>
        <narrative>Global Fund commitment to UGA-C-TASOP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="798bd2ba-0245-4c04-bb23-9d46eab5ee96">
      <transaction-type code="7" />
      <transaction-date iso-date="2022-09-09" />
      <value currency="USD" value-date="2022-09-09">4619.68</value>
      <description>
        <narrative>Funds returned to the Global Fund from UGA-C-TASOP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="3790d59a-02c6-4872-86c2-b4fc772c4d56">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-09-22" />
      <value currency="USD" value-date="2022-09-22">3298731.78</value>
      <description>
        <narrative>Global Fund disbursement to UGA-C-TASOP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="9634f084-cd35-4e7d-93af-11995a38e788">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-10-08" />
      <value currency="USD" value-date="2022-10-08">4214.89</value>
      <description>
        <narrative>Global Fund commitment to UGA-C-TASOP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="9a4a2138-38a3-4598-afc2-343f363b7faf">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-10-08" />
      <value currency="USD" value-date="2022-10-08">-8834.57</value>
      <description>
        <narrative>Global Fund commitment to UGA-C-TASOP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="03eaf257-69e1-4cfd-8afe-201bda4ad557">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-11-03" />
      <value currency="USD" value-date="2022-11-03">4204.89</value>
      <description>
        <narrative>Global Fund disbursement to UGA-C-TASOP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="8fb2265b-9003-4761-9503-b930e4e2b713">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-12-17" />
      <value currency="USD" value-date="2022-12-17">10546535.01</value>
      <description>
        <narrative>Global Fund commitment to UGA-C-TASOP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="54f4230e-6c56-4f35-89d1-c6cf7615d7ae">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-12-17" />
      <value currency="USD" value-date="2022-12-17">-3034586.69</value>
      <description>
        <narrative>Global Fund commitment to UGA-C-TASOP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="11dba673-0f6d-455c-9e42-33994e55b68b">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-12-20" />
      <value currency="USD" value-date="2022-12-20">809632.31</value>
      <description>
        <narrative>Global Fund disbursement to UGA-C-TASOP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="141685b7-183d-4b40-9778-412d4ed73fda">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-01-05" />
      <value currency="USD" value-date="2023-01-05">-10.00</value>
      <description>
        <narrative>Global Fund commitment to UGA-C-TASOP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a87faa5e-c1de-4a1e-8280-20163d62cef2">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-01-05" />
      <value currency="USD" value-date="2023-01-05">650.83</value>
      <description>
        <narrative>Global Fund commitment to UGA-C-TASOP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="8d32e3e3-026d-41b7-8e5c-855d78fddbb2">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-01-05" />
      <value currency="USD" value-date="2023-01-05">-640.83</value>
      <description>
        <narrative>Global Fund commitment to UGA-C-TASOP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="29867cd5-bd3c-4608-a540-bb1fc16cfc0c">
      <transaction-type code="7" />
      <transaction-date iso-date="2023-01-19" />
      <value currency="USD" value-date="2023-01-19">640.83</value>
      <description>
        <narrative>Funds returned to the Global Fund from UGA-C-TASOP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="0763c975-ac47-4b5e-8c34-017d3c1660ca">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-03-02" />
      <value currency="USD" value-date="2023-03-02">3717826.00</value>
      <description>
        <narrative>Global Fund disbursement to UGA-C-TASOP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="525ad9e1-1e7a-4428-8909-ccc1d583a3de">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-03-02" />
      <value currency="USD" value-date="2023-03-02">3267350.00</value>
      <description>
        <narrative>Global Fund disbursement to UGA-C-TASOP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="40d55c99-7950-4f14-a6e6-5003d8c58bf5">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-05-30" />
      <value currency="USD" value-date="2023-05-30">1059450.82</value>
      <description>
        <narrative>Global Fund disbursement to UGA-C-TASOP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="7bcdf05f-bef0-4e89-a8c6-1053e4b77f2f">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-07-04" />
      <value currency="USD" value-date="2023-07-04">1692275.53</value>
      <description>
        <narrative>Global Fund disbursement to UGA-C-TASOP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="d691a6f8-8ed2-4351-b451-5d5468d421d8">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-08-08" />
      <value currency="USD" value-date="2023-08-08">-650.83</value>
      <description>
        <narrative>Global Fund commitment to UGA-C-TASOP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="12c1a196-e483-4ead-9592-cd775ec7ccfb">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-08-17" />
      <value currency="USD" value-date="2023-08-17">8291596.32</value>
      <description>
        <narrative>Global Fund commitment to UGA-C-TASOP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="e14fc49a-3c31-4c06-a5dd-82cf6f319937">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-08-17" />
      <value currency="USD" value-date="2023-08-17">-0.35</value>
      <description>
        <narrative>Global Fund commitment to UGA-C-TASOP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="6bf3c010-5f26-41c4-8b2a-6505cccd9754">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-08-22" />
      <value currency="USD" value-date="2023-08-22">3967102.10</value>
      <description>
        <narrative>Global Fund disbursement to UGA-C-TASOP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a50e9a27-d6a1-4803-bcdb-26ef1108743e">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-11-28" />
      <value currency="USD" value-date="2023-11-28">2472955.04</value>
      <description>
        <narrative>Global Fund disbursement to UGA-C-TASOP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="4eae9b8c-cddf-4788-bc08-cfbe69a1ae6e">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-11-28" />
      <value currency="USD" value-date="2023-11-28">1851139.70</value>
      <description>
        <narrative>Global Fund disbursement to UGA-C-TASOP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0c9f1f43-7b3b-43bf-bccd-06bb3317624c">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-07-19" />
      <value currency="USD" value-date="2024-07-19">2088429.00</value>
      <description>
        <narrative>Global Fund commitment to UGA-C-TASOP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="3309270f-3147-4da5-9f69-b9f35d210d5a">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-07-19" />
      <value currency="USD" value-date="2024-07-19">-399.48</value>
      <description>
        <narrative>Global Fund commitment to UGA-C-TASOP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="bc916756-12a6-4203-9705-fb2c8f6baf1b">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-07-23" />
      <value currency="USD" value-date="2024-07-23">1291241.00</value>
      <description>
        <narrative>Global Fund disbursement to UGA-C-TASOP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="31b49d76-0c1b-4cba-a6f4-ceb668de0ef8">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-10-29" />
      <value currency="USD" value-date="2024-10-29">679144.00</value>
      <description>
        <narrative>Global Fund disbursement to UGA-C-TASOP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0895b924-4830-488d-b053-ec9f515f6439">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-02-14" />
      <value currency="USD" value-date="2025-02-14">-118044.00</value>
      <description>
        <narrative>Global Fund commitment to UGA-C-TASOP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4af85c12-8fa5-41fa-870e-7f1c817a8979">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-02-14" />
      <value currency="USD" value-date="2025-02-14">403276.00</value>
      <description>
        <narrative>Global Fund commitment to UGA-C-TASOP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="eaae4711-ee54-49b1-a6a1-f3b37f46bf7c">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-02-25" />
      <value currency="USD" value-date="2025-02-25">403276.00</value>
      <description>
        <narrative>Global Fund disbursement to UGA-C-TASOP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="73820434-ed48-4b57-8e94-21e6f82fb6fe">
      <transaction-type code="7" />
      <transaction-date iso-date="2025-08-15" />
      <value currency="USD" value-date="2025-08-15">43605.00</value>
      <description>
        <narrative>Funds returned to the Global Fund from UGA-C-TASOP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d93b9453-0a70-4b96-afb2-03790336741a">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-08-22" />
      <value currency="USD" value-date="2025-08-22">-43605.00</value>
      <description>
        <narrative>Global Fund commitment to UGA-C-TASOP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="9996cb74-0362-47f7-ada5-46d26ca8eb84">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-12-08" />
      <value currency="USD" value-date="2025-12-08">1822110.00</value>
      <description>
        <narrative>Global Fund commitment to UGA-C-TASOP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a7e4de7c-ddff-42c8-8ac8-79d13c163a20">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-12-16" />
      <value currency="USD" value-date="2025-12-16">345951.00</value>
      <description>
        <narrative>Global Fund disbursement to UGA-C-TASOP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="d5413f26-fbcc-4966-9378-a1b4e43b9065">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-02-10" />
      <value currency="USD" value-date="2026-02-10">184000.00</value>
      <description>
        <narrative>Global Fund disbursement to UGA-C-TASOP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="304a9255-a5ea-4280-b521-82f2d956286f">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-03-17" />
      <value currency="USD" value-date="2026-03-17">399142.00</value>
      <description>
        <narrative>Global Fund disbursement to UGA-C-TASOP03 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="UGA-C-TASOP03-EXP-20211231">
      <transaction-type code="4" />
      <transaction-date iso-date="2021-12-31" />
      <value currency="USD" value-date="2021-12-31">5436900.24</value>
      <description>
        <narrative>Expenditure reported by The AIDS Support Organisation (Uganda) Limited for UGA-C-TASOP03, Jan 2021 to Dec 2021.</narrative>
      </description>
      <provider-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </provider-org>
    </transaction>
    <transaction ref="UGA-C-TASOP03-EXP-20221231">
      <transaction-type code="4" />
      <transaction-date iso-date="2022-12-31" />
      <value currency="USD" value-date="2022-12-31">12577048.66</value>
      <description>
        <narrative>Expenditure reported by The AIDS Support Organisation (Uganda) Limited for UGA-C-TASOP03, Jan 2022 to Dec 2022.</narrative>
      </description>
      <provider-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </provider-org>
    </transaction>
    <transaction ref="UGA-C-TASOP03-EXP-20231231">
      <transaction-type code="4" />
      <transaction-date iso-date="2023-12-31" />
      <value currency="USD" value-date="2023-12-31">20382278.44</value>
      <description>
        <narrative>Expenditure reported by The AIDS Support Organisation (Uganda) Limited for UGA-C-TASOP03, Jan 2023 to Dec 2023.</narrative>
      </description>
      <provider-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </provider-org>
    </transaction>
    <transaction ref="UGA-C-TASOP03-EXP-20240630">
      <transaction-type code="4" />
      <transaction-date iso-date="2024-06-30" />
      <value currency="USD" value-date="2024-06-30">1597906.38</value>
      <description>
        <narrative>Expenditure reported by The AIDS Support Organisation (Uganda) Limited for UGA-C-TASOP03, Jan 2024 to Jun 2024.</narrative>
      </description>
      <provider-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </provider-org>
    </transaction>
    <transaction ref="UGA-C-TASOP03-EXP-20241231">
      <transaction-type code="4" />
      <transaction-date iso-date="2024-12-31" />
      <value currency="USD" value-date="2024-12-31">678835.00</value>
      <description>
        <narrative>Expenditure reported by The AIDS Support Organisation (Uganda) Limited for UGA-C-TASOP03, Jul 2024 to Dec 2024.</narrative>
      </description>
      <provider-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </provider-org>
    </transaction>
    <transaction ref="UGA-C-TASOP03-EXP-20250630">
      <transaction-type code="4" />
      <transaction-date iso-date="2025-06-30" />
      <value currency="USD" value-date="2025-06-30">699225.00</value>
      <description>
        <narrative>Expenditure reported by The AIDS Support Organisation (Uganda) Limited for UGA-C-TASOP03, Jan 2025 to Jun 2025.</narrative>
      </description>
      <provider-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </provider-org>
    </transaction>
    <transaction ref="UGA-C-TASOP03-EXP-20251231">
      <transaction-type code="4" />
      <transaction-date iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-12-31">2370551.41</value>
      <description>
        <narrative>Expenditure reported by The AIDS Support Organisation (Uganda) Limited for UGA-C-TASOP03, Jan 2025 to Dec 2025.</narrative>
      </description>
      <provider-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/UGA-C-TASO" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-12" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <document-link url="https://docs.theglobalfund.org/files/Applications/Funding Requests/UGA/2020/TB_HIV/en/UGA-C_FundingRequest_1_en.zip" format="application/zip">
      <title>
        <narrative>2020 - Funding Request - Window 1 - TB/HIV - Uganda - English</narrative>
      </title>
      <description>
        <narrative>Funding Request of funding request FR680-UGA-C.</narrative>
      </description>
      <category code="A01" />
      <category code="A02" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2020-03-23" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of adolescent girls and young women who were tested for HIV and received their results during the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of adolescent girls and young women who were tested for HIV and received their results during the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="5736" />
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="6255" />
          <actual value="1035" />
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="12510" />
          <actual value="6835" />
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="6255" />
          <actual value="5800" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="6285" />
          <actual value="5230" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="12570" />
          <actual value="11759" />
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="6285" />
          <actual value="6529" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="12510" />
          <actual value="12252" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="6255" />
          <actual value="5234" />
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="6255" />
          <actual value="7018" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of men who have sex with men that have received an HIV test during the reporting period and know their results</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of men who have sex with men that have received an HIV test during the reporting period and know their results</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31">
          <comment>
            <narrative>Numerator: 4938.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 5333.04; Denominator: 5925.6; Percentage: 90%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3441; Denominator: 5925; Percentage: 58.1%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 10666; Denominator: 11851.2; Percentage: 90%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 8504; Denominator: 11851; Percentage: 71.8%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 5333.04; Denominator: 5925.6; Percentage: 90%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 5063; Denominator: 5926; Percentage: 85.4%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 6399.65; Denominator: 7110.72; Percentage: 90%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 10308; Denominator: 7111; Percentage: 145%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 12799.2; Denominator: 14221.4; Percentage: 90%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 21241; Denominator: 14222; Percentage: 149.4%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 6399.65; Denominator: 7110.72; Percentage: 90%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 10933; Denominator: 7111; Percentage: 153.7%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 15360; Denominator: 17066; Percentage: 90%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 13384; Denominator: 17066; Percentage: 78.4%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 7680; Denominator: 8533; Percentage: 90%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 7484; Denominator: 8533; Percentage: 87.7%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 7680; Denominator: 8533; Percentage: 90%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 5900; Denominator: 8533; Percentage: 69.1%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of sex workers that have received an HIV test during the reporting period and know their results</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of sex workers that have received an HIV test during the reporting period and know their results</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31">
          <comment>
            <narrative>Numerator: 17094.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 40000; Denominator: 44444.4; Percentage: 90%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 37645; Denominator: 44444; Percentage: 84.7%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 19999.98; Denominator: 22222.2; Percentage: 90%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 16292; Denominator: 22222; Percentage: 73.3%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 19999.98; Denominator: 22222.2; Percentage: 90%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 21353; Denominator: 22222; Percentage: 96.1%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 25999.97; Denominator: 28888.86; Percentage: 90%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 30687; Denominator: 28889; Percentage: 106.2%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 52000; Denominator: 57777.8; Percentage: 90%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 74282; Denominator: 57778; Percentage: 128.6%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 25999.97; Denominator: 28888.86; Percentage: 90%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 43595; Denominator: 28889; Percentage: 150.9%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 67600; Denominator: 75112; Percentage: 90%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 64447; Denominator: 75112; Percentage: 85.8%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 33800; Denominator: 37556; Percentage: 90%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 38437; Denominator: 37556; Percentage: 102.3%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 33800; Denominator: 37556; Percentage: 90%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 26010; Denominator: 37556; Percentage: 69.3%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of adolescent girls and young women reached with HIV prevention programs- defined package of services</narrative>
      </title>
      <description>
        <narrative>Module: Prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of adolescent girls and young women reached with HIV prevention programs- defined package of services</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31">
          <comment>
            <narrative>Numerator: 23250.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 41700; Denominator: 453990; Percentage: 9.2%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 30570; Denominator: 453990; Percentage: 6.7%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 20850; Denominator: 226995; Percentage: 9.19%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1773; Denominator: 226995; Percentage: 0.8%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 20850; Denominator: 226995; Percentage: 9.19%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 28797; Denominator: 226995; Percentage: 12.7%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 20950; Denominator: 226995; Percentage: 9.23%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 26697; Denominator: 226995; Percentage: 11.8%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 41900; Denominator: 453990; Percentage: 9.2%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 61384; Denominator: 453990; Percentage: 13.5%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 20950; Denominator: 226995; Percentage: 9.23%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 34687; Denominator: 226995; Percentage: 15.3%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 20850; Denominator: 226995; Percentage: 9.19%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 19401; Denominator: 226995; Percentage: 8.5%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 41700; Denominator: 453990; Percentage: 9.2%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 43036; Denominator: 453990; Percentage: 9.5%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 20850; Denominator: 226995; Percentage: 9.19%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 23635; Denominator: 226995; Percentage: 10.4%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of men who have sex with men reached with HIV prevention programs</narrative>
      </title>
      <description>
        <narrative>Module: Prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of men who have sex with men reached with HIV prevention programs</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31">
          <comment>
            <narrative>Numerator: 4938.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 11851.2; Denominator: 61724; Percentage: 19.2%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 8297; Denominator: 61724; Percentage: 13.4%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 5925.6; Denominator: 30862; Percentage: 19.2%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3218; Denominator: 30862; Percentage: 10.4%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 5925.6; Denominator: 30862; Percentage: 19.2%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 5079; Denominator: 30862; Percentage: 16.5%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 7110.72; Denominator: 30862; Percentage: 23.04%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 10368; Denominator: 30862; Percentage: 33.6%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 14221.4; Denominator: 61724; Percentage: 23%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 21325; Denominator: 61724; Percentage: 34.5%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 7110.72; Denominator: 30862; Percentage: 23.04%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 10957; Denominator: 30862; Percentage: 35.5%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 17065.8; Denominator: 61724; Percentage: 27.6%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 13825; Denominator: 61724; Percentage: 22.4%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 8532.86; Denominator: 30862; Percentage: 27.65%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 7473; Denominator: 30862; Percentage: 24.2%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 8532.86; Denominator: 30862; Percentage: 27.65%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 6352; Denominator: 30862; Percentage: 20.6%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of sex workers reached with HIV prevention programs</narrative>
      </title>
      <description>
        <narrative>Module: Prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of sex workers reached with HIV prevention programs</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31">
          <comment>
            <narrative>Numerator: 17094.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 44444.2; Denominator: 221200; Percentage: 20.1%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 37441; Denominator: 221200; Percentage: 16.9%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 22222; Denominator: 110600; Percentage: 20.09%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 16031; Denominator: 110600; Percentage: 14.5%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 22222.2; Denominator: 110600; Percentage: 20.09%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 21410; Denominator: 110600; Percentage: 19.4%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 28888.86; Denominator: 110600; Percentage: 26.12%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 31045; Denominator: 110600; Percentage: 28.1%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 57777.8; Denominator: 221200; Percentage: 26.1%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 75594; Denominator: 221200; Percentage: 34.2%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 28888.86; Denominator: 110600; Percentage: 26.12%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 44549; Denominator: 110600; Percentage: 40.3%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 75111; Denominator: 221200; Percentage: 34%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 67430; Denominator: 221200; Percentage: 30.5%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 37555.52; Denominator: 110600; Percentage: 33.96%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 38441; Denominator: 110600; Percentage: 34.8%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 37555.52; Denominator: 110600; Percentage: 33.96%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 28989; Denominator: 110600; Percentage: 26.2%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of people in contact with TB patients who began preventive therapy</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of people in contact with TB patients who began preventive therapy</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="5215" />
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="39141" />
          <actual value="9791" />
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="78282" />
          <actual value="22119" />
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="39141" />
          <actual value="12328" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="46259" />
          <actual value="55409" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="92519" />
          <actual value="134664" />
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="46260" />
          <actual value="79255" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="61578" />
          <actual value="117411" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="123156" />
          <actual value="244274" />
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="61578" />
          <actual value="126863" />
        </period>
      </indicator>
    </result>
  </iati-activity>
  <iati-activity last-updated-datetime="2026-11-12T12:45:29+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-UGA-C-TASO-4</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Supporting Uganda’s Response to HIV/AIDS and Tuberculosis Reduction Strategy - Uganda (01-Jan-2024-31-Dec-2026)</narrative>
    </title>
    <description type="1">
      <narrative>Uganda, TB/HIV, The AIDS Support Organisation (Uganda) Limited</narrative>
    </description>
    <description type="2">
      <narrative>Goal: Increase productivity, inclusiveness and well-being of the population by ending HIV and AIDS as an epidemic by 2030. Objectives: To reduce new HIV infections by 65% among adults and youth, and to reduce new paediatric HIV infections to less than 5% by 2025; To reduce AIDS-related morbidity and mortality by 2025; To strengthen social and economic protection to reduce vulnerability to HIV and AIDS and to mitigate their impact on people living with HIV, orphans and other vulnerable children (OVC), KPs and other vulnerable groups; To strengthen the multi-sectoral HIV and AIDS service delivery and coordination system that ensures sustainable access to efficient and quality services for all focus populations; To strengthen the national HIV and AIDS strategic information management system for improved effectiveness and efficiency.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="24" role="2" crs-channel-code="23000">
      <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
    </participating-org>
    <participating-org type="24" role="4" crs-channel-code="23000">
      <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
    </participating-org>
    <other-identifier ref="UGA-C-TASOP04" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="2" />
    <activity-date type="1" iso-date="2024-01-01" />
    <activity-date type="2" iso-date="2024-01-01" />
    <activity-date type="3" iso-date="2026-12-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>Saman Zamani</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>saman.zamani@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="UG" percentage="100">
      <narrative>Uganda</narrative>
    </recipient-country>
    <sector vocabulary="1" code="13040" percentage="46.12">
      <narrative>HIV</narrative>
    </sector>
    <sector vocabulary="1" code="12110" percentage="39.12">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <sector vocabulary="1" code="12263" percentage="14.76">
      <narrative>Tuberculosis</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="aecf0171-ec0b-4298-be44-3c2a390d7a69" percentage="0.53">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Community-based testing for KP programs</narrative>
        </description>
      </budget-item>
      <budget-item code="e41c9e1f-dfcd-4d62-9a3d-2c6d760bb3af" percentage="0.36">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Facility-based testing for key population (KP) programs</narrative>
        </description>
      </budget-item>
      <budget-item code="26ab57aa-470b-4e99-bff9-92e1452cf6cd" percentage="0.18">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Facility-based testing outside of key population (KP) and adolescent girls and young women (AGYW) programs</narrative>
        </description>
      </budget-item>
      <budget-item code="48867067-7709-4cef-94a9-7dcc66211686" percentage="0.51">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Self-testing for KP programs</narrative>
        </description>
      </budget-item>
      <budget-item code="8549b926-d8fb-4fa0-b3b8-79fc250303b6" percentage="1.87">
        <description>
          <narrative>HIV -&gt; Prevention package for adolescent girls and young women (AGYW) and male sexual partners in high HIV incidence settings -&gt; Comprehensive sexuality education for adolescent girls and young women (AGYW) and adolescent boys and young men (ABYM)</narrative>
        </description>
      </budget-item>
      <budget-item code="40398828-3a09-4ca0-8dde-b3d7a66d7158" percentage="7.2">
        <description>
          <narrative>HIV -&gt; Prevention package for adolescent girls and young women (AGYW) and male sexual partners in high HIV incidence settings -&gt; HIV prevention communication, information and demand creation for male sexual partners of AGYW in high HIV incidence settings</narrative>
        </description>
      </budget-item>
      <budget-item code="5c4d112f-f0f4-4a20-8ac8-5c566f7aa322" percentage="0.17">
        <description>
          <narrative>HIV -&gt; Prevention package for adolescent girls and young women (AGYW) and male sexual partners in high HIV incidence settings -&gt; Removing human rights-related barriers to prevention for AGYW in high HIV incidence settings</narrative>
        </description>
      </budget-item>
      <budget-item code="e71b58f8-6d5d-4f73-93c5-cea93aefb0c3" percentage="11.26">
        <description>
          <narrative>HIV -&gt; Prevention package for adolescent girls and young women (AGYW) and male sexual partners in high HIV incidence settings -&gt; Sexual and reproductive health services, including STIs, hepatitis, post-violence care for AGYW and male sexual partners in high HIV incidence settings</narrative>
        </description>
      </budget-item>
      <budget-item code="6fcd5647-f3de-44bd-8c27-be59771546a9" percentage="6.64">
        <description>
          <narrative>HIV -&gt; Prevention package for adolescent girls and young women (AGYW) and male sexual partners in high HIV incidence settings -&gt; Social protection interventions for AGYW in high HIV incidence settings</narrative>
        </description>
      </budget-item>
      <budget-item code="92423e34-c66c-47f4-9cac-58b9e0ea01fc" percentage="0.68">
        <description>
          <narrative>HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; Community empowerment for MSM</narrative>
        </description>
      </budget-item>
      <budget-item code="7a803e07-8560-47f6-9b59-72193d6812db" percentage="0.26">
        <description>
          <narrative>HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; Condom and lubricant programming for MSM</narrative>
        </description>
      </budget-item>
      <budget-item code="86dc2898-1dfb-4559-a4cb-72cd5a2cd403" percentage="0.33">
        <description>
          <narrative>HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; HIV prevention communication, information and demand creation for MSM</narrative>
        </description>
      </budget-item>
      <budget-item code="b7a2ebc7-33dc-42f2-b664-e760a5d99b0a" percentage="0.15">
        <description>
          <narrative>HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; Removing human rights-related barriers to prevention for MSM</narrative>
        </description>
      </budget-item>
      <budget-item code="52020c8d-d3b6-42f6-9137-038784523b8a" percentage="0.27">
        <description>
          <narrative>HIV -&gt; Prevention package for other vulnerable populations (OVP) -&gt; Condom and lubricant programming for OVP</narrative>
        </description>
      </budget-item>
      <budget-item code="97e87d65-a4de-4357-81ae-2aae27b112a2" percentage="1.29">
        <description>
          <narrative>HIV -&gt; Prevention package for other vulnerable populations (OVP) -&gt; HIV prevention communication, information and demand creation for OVP</narrative>
        </description>
      </budget-item>
      <budget-item code="09268318-342f-41af-84e1-0aab4e2fd8f3" percentage="0.28">
        <description>
          <narrative>HIV -&gt; Prevention package for people who use drugs (PUD) and their sexual partners -&gt; Community empowerment for PUD</narrative>
        </description>
      </budget-item>
      <budget-item code="1d7ecc3b-d5b9-48ca-a9e7-d8fa38cf3455" percentage="0.13">
        <description>
          <narrative>HIV -&gt; Prevention package for people who use drugs (PUD) and their sexual partners -&gt; Condom and lubricant programming for PUD</narrative>
        </description>
      </budget-item>
      <budget-item code="49ef45b6-ef30-48b1-b393-f34c25d513c4" percentage="0.3">
        <description>
          <narrative>HIV -&gt; Prevention package for people who use drugs (PUD) and their sexual partners -&gt; Opioid substitution therapy and other medically assisted drug dependence treatment for PWID</narrative>
        </description>
      </budget-item>
      <budget-item code="e2889950-b814-4736-95c3-6957c4461ebe" percentage="0.24">
        <description>
          <narrative>HIV -&gt; Prevention package for people who use drugs (PUD) and their sexual partners -&gt; Pre-exposure prophylaxis (PrEP) programming for PUD</narrative>
        </description>
      </budget-item>
      <budget-item code="10c0f677-be26-46fb-a1c0-17c238f89b7e" percentage="0.13">
        <description>
          <narrative>HIV -&gt; Prevention package for people who use drugs (PUD) and their sexual partners -&gt; Removing human rights-related barriers to prevention for PUD</narrative>
        </description>
      </budget-item>
      <budget-item code="12d964e1-5c4b-4caa-9b00-225bb89861dd" percentage="0.08">
        <description>
          <narrative>HIV -&gt; Prevention package for sex workers, their clients and other sexual partners -&gt; Community empowerment for sex workers</narrative>
        </description>
      </budget-item>
      <budget-item code="94dbd87e-0cec-46fb-83f5-7c805de185cb" percentage="0.89">
        <description>
          <narrative>HIV -&gt; Prevention package for sex workers, their clients and other sexual partners -&gt; Condom and lubricant programming for sex workers</narrative>
        </description>
      </budget-item>
      <budget-item code="394d6538-8808-4811-b96b-d6bf71843cb6" percentage="0.54">
        <description>
          <narrative>HIV -&gt; Prevention package for sex workers, their clients and other sexual partners -&gt; HIV prevention communication, information and demand creation for sex workers</narrative>
        </description>
      </budget-item>
      <budget-item code="4ad468bf-4376-466e-944a-b25f3e1b00ee" percentage="2.16">
        <description>
          <narrative>HIV -&gt; Prevention package for sex workers, their clients and other sexual partners -&gt; Pre-exposure prophylaxis (PrEP) programming for sex workers</narrative>
        </description>
      </budget-item>
      <budget-item code="3f39233d-f679-42ce-8532-a7949f0d93ef" percentage="0.15">
        <description>
          <narrative>HIV -&gt; Prevention package for sex workers, their clients and other sexual partners -&gt; Sexual and reproductive health services, including STIs, hepatitis, post-violence care for sex workers</narrative>
        </description>
      </budget-item>
      <budget-item code="c1c1a139-7603-46fe-a10f-3766fac53456" percentage="0.06">
        <description>
          <narrative>HIV -&gt; Prevention package for transgender people and their sexual partners -&gt; Community empowerment for transgender people</narrative>
        </description>
      </budget-item>
      <budget-item code="6853dd18-909c-4836-8981-2e434afc456c" percentage="0.54">
        <description>
          <narrative>HIV -&gt; Prevention package for transgender people and their sexual partners -&gt; Pre-exposure prophylaxis (PrEP) programming for transgender people</narrative>
        </description>
      </budget-item>
      <budget-item code="58b982df-6d9f-4cf8-8a29-3e452601002f" percentage="0.04">
        <description>
          <narrative>HIV -&gt; Prevention package for transgender people and their sexual partners -&gt; Removing human rights-related barriers to prevention for transgender people</narrative>
        </description>
      </budget-item>
      <budget-item code="e6662a80-0f0d-4611-990c-6044696834dc" percentage="0.5">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Community mobilization and advocacy for human rights</narrative>
        </description>
      </budget-item>
      <budget-item code="9bcc0e33-1356-4897-a1b3-d9171e326a60" percentage="0.77">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Eliminating stigma and discrimination in all settings</narrative>
        </description>
      </budget-item>
      <budget-item code="39d71dad-c8af-467d-9fcc-8ac534b86784" percentage="0.59">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Ensuring nondiscriminatory provision of health care</narrative>
        </description>
      </budget-item>
      <budget-item code="10e03ea0-16be-40e1-9fba-682edec921d0" percentage="0.23">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Ensuring rights-based law enforcement practices</narrative>
        </description>
      </budget-item>
      <budget-item code="b745fdfb-055f-428b-9634-646cf15f5904" percentage="0.18">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Improving laws, regulations and policies relating to HIV and HIV/TB</narrative>
        </description>
      </budget-item>
      <budget-item code="28c1900d-472f-4af5-94d7-2b92f93ab743" percentage="2.77">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Increasing access to justice (HIV/TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="ecc245de-32bf-41ff-8eb1-f5fae2eb1557" percentage="3.85">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Legal literacy ("Know Your Rights") (HIV/TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="cd09d6c8-13e6-412e-a54d-84c32d99a370" percentage="0.87">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Coordination and management of national disease control programs</narrative>
        </description>
      </budget-item>
      <budget-item code="43337786-bfab-487f-b388-9fbe8808948d" percentage="22.28">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="3cd53114-9428-41ec-bcc9-02a0048f7a4c" percentage="1.57">
        <description>
          <narrative>RSSH -&gt; RSSH/PP: Human resources for health (HRH) and quality of care -&gt; RSSH/PP: Community health workers: selection, pre-service training and certification</narrative>
        </description>
      </budget-item>
      <budget-item code="9fa6654d-29f0-4b9e-9de9-674479de3110" percentage="0.06">
        <description>
          <narrative>RSSH -&gt; RSSH/PP: Human resources for health (HRH) and quality of care -&gt; RSSH/PP: In-service training (excluding community health workers)</narrative>
        </description>
      </budget-item>
      <budget-item code="ee47d3a5-497f-4999-baac-60877b4cf497" percentage="1.59">
        <description>
          <narrative>RSSH -&gt; RSSH/PP: Human resources for health (HRH) and quality of care -&gt; RSSH/PP: Integrated supportive supervision for health workers (excluding CHWs)</narrative>
        </description>
      </budget-item>
      <budget-item code="cd617bfe-5123-4888-8f4c-d3ff4f3eddce" percentage="1.1">
        <description>
          <narrative>RSSH -&gt; RSSH/PP: Human resources for health (HRH) and quality of care -&gt; RSSH/PP: Remuneration and deployment of existing/new staff (excluding community health workers)</narrative>
        </description>
      </budget-item>
      <budget-item code="db62704e-5b08-4eb1-b5cb-39a697705c19" percentage="4.57">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Capacity building and leadership development</narrative>
        </description>
      </budget-item>
      <budget-item code="7dbf6454-4357-4937-89a1-9a1c7f0174fa" percentage="1.48">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Community engagement, linkages and coordination</narrative>
        </description>
      </budget-item>
      <budget-item code="8c042996-0cb7-4540-ad17-483cf18ec784" percentage="5.04">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Community-led monitoring</narrative>
        </description>
      </budget-item>
      <budget-item code="12d82614-1fc1-4696-b954-b899115b31d9" percentage="0.56">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Community-led research and advocacy</narrative>
        </description>
      </budget-item>
      <budget-item code="5b20da70-c625-405c-858b-6de52626ae46" percentage="8.06">
        <description>
          <narrative>Tuberculosis -&gt; Drug-resistant (DR)-TB diagnosis, treatment and care -&gt; DR-TB treatment, care and support</narrative>
        </description>
      </budget-item>
      <budget-item code="003bd5ec-d813-43cd-9bae-ec060870a2c4" percentage="1.52">
        <description>
          <narrative>Tuberculosis -&gt; TB diagnosis, treatment and care -&gt; TB treatment, care and support</narrative>
        </description>
      </budget-item>
      <budget-item code="68262ac7-05ab-4aec-9c9e-320d5883c55c" percentage="5.17">
        <description>
          <narrative>Tuberculosis -&gt; TB/DR-TB Prevention -&gt; Screening/testing for TB infection</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2024-01-01" />
      <period-end iso-date="2024-12-31" />
      <value currency="USD" value-date="2024-01-01">8514526.89</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2025-01-01" />
      <period-end iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-01-01">17992897.71</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2026-01-01" />
      <period-end iso-date="2026-12-31" />
      <value currency="USD" value-date="2026-01-01">15758125.73</value>
    </budget>
    <capital-spend percentage="9.57" />
    <transaction ref="6323cb1b-c763-4bf1-bcce-0d0f7b04f372">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-12-22" />
      <value currency="USD" value-date="2023-12-22">25696137.44</value>
      <description>
        <narrative>Global Fund commitment to UGA-C-TASOP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="0112c1db-ccea-41bf-9bf7-ef87212a9507">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-01-04" />
      <value currency="USD" value-date="2024-01-04">4441658.01</value>
      <description>
        <narrative>Global Fund disbursement to UGA-C-TASOP04 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a07db07f-2bba-48a3-a071-9106cfb9b0cb">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-07-25" />
      <value currency="USD" value-date="2024-07-25">2653005.00</value>
      <description>
        <narrative>Global Fund disbursement to UGA-C-TASOP04 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="584a13d8-b56a-4fb0-bf9d-9dfcccab93d5">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-10-15" />
      <value currency="USD" value-date="2024-10-15">6792784.00</value>
      <description>
        <narrative>Global Fund disbursement to UGA-C-TASOP04 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="5c993252-ff3e-408f-8157-ab5dbd79a73b">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-04-10" />
      <value currency="USD" value-date="2025-04-10">6544514.56</value>
      <description>
        <narrative>Global Fund disbursement to UGA-C-TASOP04 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="599f858a-ca9c-44d0-b83b-6b9de0eb1455">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-11-15" />
      <value currency="USD" value-date="2025-11-15">15089530.28</value>
      <description>
        <narrative>Global Fund commitment to UGA-C-TASOP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="df14e0a6-6704-4ae1-bd94-44140b0cbbe7">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-11-15" />
      <value currency="USD" value-date="2025-11-15">-5264175.87</value>
      <description>
        <narrative>Global Fund commitment to UGA-C-TASOP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="cb81e836-9122-4ad6-9a5f-bc6888a3846b">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-11-18" />
      <value currency="USD" value-date="2025-11-18">6989107.62</value>
      <description>
        <narrative>Global Fund disbursement to UGA-C-TASOP04 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="66eaea83-fe51-4a9d-938e-77344f51477e">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-04-08" />
      <value currency="USD" value-date="2026-04-08">3696160.92</value>
      <description>
        <narrative>Global Fund disbursement to UGA-C-TASOP04 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="cb6f38a3-b564-4e7b-9d63-2dcf7743e3f2">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-07-07" />
      <value currency="USD" value-date="2026-07-07">4404000.00</value>
      <description>
        <narrative>Global Fund disbursement to UGA-C-TASOP04 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="195ad796-2984-4975-b909-2036808d3ab5">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-09-23" />
      <value currency="USD" value-date="2026-09-23">4905257.52</value>
      <description>
        <narrative>Global Fund commitment to UGA-C-TASOP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="fddc2acd-9658-4177-b56f-bfbfa28aa6e6">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-09-23" />
      <value currency="USD" value-date="2026-09-23">-261.74</value>
      <description>
        <narrative>Global Fund commitment to UGA-C-TASOP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="50ba5e6c-c2f3-4aa5-b06c-96a5bc8caf8c">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-09-29" />
      <value currency="USD" value-date="2026-09-29">4822449.92</value>
      <description>
        <narrative>Global Fund disbursement to UGA-C-TASOP04 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="UGA-C-TASOP04-EXP-20241231">
      <transaction-type code="4" />
      <transaction-date iso-date="2024-12-31" />
      <value currency="USD" value-date="2024-12-31">8514527.00</value>
      <description>
        <narrative>Expenditure reported by The AIDS Support Organisation (Uganda) Limited for UGA-C-TASOP04, Jan 2024 to Dec 2024.</narrative>
      </description>
      <provider-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </provider-org>
    </transaction>
    <transaction ref="UGA-C-TASOP04-EXP-20251231">
      <transaction-type code="4" />
      <transaction-date iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-12-31">13246883.23</value>
      <description>
        <narrative>Expenditure reported by The AIDS Support Organisation (Uganda) Limited for UGA-C-TASOP04, Jan 2025 to Dec 2025.</narrative>
      </description>
      <provider-org type="24">
        <narrative>The AIDS Support Organisation (Uganda) Limited</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/UGA-C-TASO" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-12" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <document-link url="https://docs.theglobalfund.org/files/Applications/Funding Requests/UGA/2023/TB_HIV/en/UGA-C_FundingRequest_1_en.zip" format="application/zip">
      <title>
        <narrative>2023 - Funding Request - Window 1 - TB/HIV - Uganda - English</narrative>
      </title>
      <description>
        <narrative>Funding Request of funding request FR1408-UGA-C.</narrative>
      </description>
      <category code="A01" />
      <category code="A02" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2023-03-30" />
    </document-link>
    <conditions attached="1">
      <condition type="1">
        <narrative>1 - Personal Data (1) Principles. The Principal Recipient, acknowledges that Program Activities are expected to respect the following principles and rights (“Data Protection Principles”): (a) Information that could be used to identify a natural person (“Personal Data”) will be: (i) processed lawfully, fairly and transparently; (ii) collected for specified, explicit and legitimate purposes and not further processed in a manner not compatible with those purposes;  (iii) adequate, relevant and limited to what is necessary for the purposes for which they are processed; (iv) accurate and, where necessary, kept up to date; (v) kept in a form which permits identification of the individuals for no longer than is necessary for the purposes for which the Personal Data is processed; and (vi) processed in a manner that ensures appropriate security of the Personal Data; and (b) Natural persons are afforded, where relevant, the right to information about Personal Data that is processed; the right to access and rectify or erase Personal Data; the right to data portability; the right to confidentiality of electronic communications; and the right to object to processing. (2) Limitations. Where collection and processing of Personal Data is required in order to implement Program Activities, whether by the Principal Recipient, a Sub-recipient, or Supplier, the Principal Recipient should respect the Data Protection Principles: (a) to the extent that doing so does not violate or conflict with applicable law and/or policy; and (b) subject to the Principal Recipient balancing the Data Protection Principles with other fundamental rights in accordance with the principle of proportionality, taking into account the risks to the rights and freedoms of natural persons.</narrative>
      </condition>
      <condition type="1">
        <narrative>2 - With respect to Section 7.6 (Right of Access) of the Global Fund Grant Regulations (as amended from time to time), (1) the Global Fund may collect or seek to collect data, and it is possible that such data may contain Personal Data, and (2), prior to collection and at all times thereafter, the Principal Recipient shall take all necessary actions to ensure that the transfer of such information to the Global Fund does not violate any applicable law or regulation.</narrative>
      </condition>
      <condition type="1">
        <narrative>3 - (1) In accordance with the Global Fund’s Sustainability, Transition and Co-financing Policy (GF/B35/04) (the “STC Policy”), the commitment and disbursement of USD 50,231,518 (the “Co-Financing Incentive”), is subject to the Global Fund’s satisfaction with the Host Country’s compliance with the requirements listed at 5.3(1)(a) and 5.3(1)(b) below (“Co-Financing Requirements”). The Grantee acknowledges and agrees that the Global Fund may reduce Grant Funds during the current or any subsequent Implementation Period in the event the Host Country fails to: (a) increase government expenditure on health to meet national universal health coverage goals; and/or (b) maintain domestic funding of Global Fund-supported programs, with a focus on progressively absorbing the key costs of national disease plans, as identified in consultation with the Global Fund. (2) In order to satisfy the Co-Financing Requirements, the Grantee acknowledges and agrees that the Host Country shall, as set out in the Commitment Letter, dated 23 October 2023 (the “Commitment Letter”), unless otherwise agreed in writing with the Global Fund: (a) fulfil a total minimum co-financing commitment of USD 615,330,000, comprising investments in: i. HIV of USD 246,150,000; ii. TB of USD 8,450,000; iii. RSSH of USD 360,730,000; (b) fulfil the programmatic commitments as stipulated in Table 2 of the Commitment Letter: i. sustain and increase the financing for HIV/AIDS commodities including ARVs, and testing reagents to avoid drug stockouts for a total amount of USD 246,150,000 over the Implementation Period; and ii. increase diagnostic of HIV to 95% of people living with HIV, enroll 95% on ART and achieve viral load suppression in 95% of people on ART; iii. sustain the financing for TB medicines both in public and in private-not-for-profit (PNFP) facilities for a total amount of USD 8,450,000 over the Implementation Period; iv. increase treatment coverage and treatment success rate for Tuberculosis from 87% to 90%; and (c) provide to the Global Fund each year of the Implementation Period and the year following the end of the Implementation Period, evidence supporting achievement of the Co-Financing Requirements, including: i. the Approved Annual Budget Estimates, including allocation for HIV / TB / RSSH, and overall health for the upcoming year by 15 June of every year; ii. the Annual Budget Performance Report, including total expenditure for HIV / TB / RSSH, and overall health incurred in the previous fiscal year by 30 October of every year.</narrative>
      </condition>
      <condition type="2">
        <narrative>4 - The Program budget may be funded in part by Grant Funds disbursed under a previous Grant Agreement, which the Global Fund has approved to be used for the Program under the current Grant Agreement (“Previously Disbursed Grant Funds”), as well as additional Grant Funds up to the amount set forth in Section 3.6. hereof. Accordingly, the Global Fund may reduce the amount of Grant Funds set forth in Section 3.6. hereof by the amount of any Previously Disbursed Grant Funds. Previously Disbursed Grant Funds shall be governed by the terms of this Grant Agreement.</narrative>
      </condition>
      <condition type="3">
        <narrative>5 - The procurement of Health Products shall be carried out through the Pooled Procurement Mechanism (“PPM”) of the Global Fund, unless the Global Fund directs the Principal Recipient otherwise in writing. The Principal Recipient has all the necessary power and authority to execute, deliver and carry out its obligations under the wambo.org – PPM registration letter in the form a–proved by the Global Fund.</narrative>
      </condition>
    </conditions>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of at-risk AGYW that have received an HIV test during the reporting period in AGYW programs</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of at-risk AGYW that have received an HIV test during the reporting period in AGYW programs</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - special.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="12.11">
          <comment>
            <narrative>Numerator: 11808; Denominator: 97520.56.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="44.5">
          <dimension name="Age" value="15-19" />
          <comment>
            <narrative>Numerator: 5254; Denominator: 11808.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="44.5">
          <dimension name="Age" value="15-19" />
          <comment>
            <narrative>Numerator: 5254; Denominator: 11808.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="47.54">
          <dimension name="Age" value="20-24" />
          <comment>
            <narrative>Numerator: 5614; Denominator: 11808.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="47.54">
          <dimension name="Age" value="20-24" />
          <comment>
            <narrative>Numerator: 5614; Denominator: 11808.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="8.12">
            <comment>
              <narrative>Numerator: 10091.25; Denominator: 124202.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="24.4">
            <comment>
              <narrative>Numerator: 30273.8; Denominator: 124202.</narrative>
            </comment>
          </target>
          <actual value="32.45">
            <comment>
              <narrative>Numerator: 40300; Denominator: 124202.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="16.25">
            <comment>
              <narrative>Numerator: 20182.5; Denominator: 124202.</narrative>
            </comment>
          </target>
          <actual value="28.44">
            <comment>
              <narrative>Numerator: 35320; Denominator: 124202.</narrative>
            </comment>
          </actual>
          <actual value="44.09">
            <dimension name="Age" value="15-19" />
            <comment>
              <narrative>Numerator: 17767; Denominator: 40300.</narrative>
            </comment>
          </actual>
          <actual value="52.45">
            <dimension name="Age" value="20-24" />
            <comment>
              <narrative>Numerator: 21138; Denominator: 40300.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="16.25">
            <comment>
              <narrative>Numerator: 20730.45; Denominator: 127571.23.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="32.5">
            <comment>
              <narrative>Numerator: 41461; Denominator: 127571.2.</narrative>
            </comment>
          </target>
          <actual value="33.29">
            <comment>
              <narrative>Numerator: 42467; Denominator: 127571.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="16.25">
            <comment>
              <narrative>Numerator: 20730.45; Denominator: 127571.23.</narrative>
            </comment>
          </target>
          <actual value="17.64">
            <comment>
              <narrative>Numerator: 22509; Denominator: 127571.</narrative>
            </comment>
          </actual>
          <actual value="44.49">
            <dimension name="Age" value="15-19" />
            <comment>
              <narrative>Numerator: 18894; Denominator: 42467.</narrative>
            </comment>
          </actual>
          <actual value="52.58">
            <dimension name="Age" value="20-24" />
            <comment>
              <narrative>Numerator: 22328; Denominator: 42467.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="16.25">
            <comment>
              <narrative>Numerator: 21352.5; Denominator: 131398.37.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="16.25">
            <comment>
              <narrative>Numerator: 21352.5; Denominator: 131398.37.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of other vulnerable people that have received an HIV test during the reporting period and know their results</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of other vulnerable people that have received an HIV test during the reporting period and know their results</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="43.92">
          <comment>
            <narrative>Numerator: 10620.5; Denominator: 24179.2.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="41.9">
            <comment>
              <narrative>Numerator: 11154; Denominator: 26634.2.</narrative>
            </comment>
          </target>
          <actual value="63.46">
            <comment>
              <narrative>Numerator: 16901; Denominator: 26634.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="41.88">
            <comment>
              <narrative>Numerator: 11153.95; Denominator: 26634.16.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="41.88">
            <comment>
              <narrative>Numerator: 11153.95; Denominator: 26634.16.</narrative>
            </comment>
          </target>
          <actual value="63.46">
            <comment>
              <narrative>Numerator: 16901; Denominator: 26634.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="48.89">
            <comment>
              <narrative>Numerator: 13020.7; Denominator: 26634.16.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="48.9">
            <comment>
              <narrative>Numerator: 13020.7; Denominator: 26634.2.</narrative>
            </comment>
          </target>
          <actual value="45.54">
            <comment>
              <narrative>Numerator: 12130; Denominator: 26634.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="48.89">
            <comment>
              <narrative>Numerator: 13020.7; Denominator: 26634.16.</narrative>
            </comment>
          </target>
          <actual value="45.54">
            <comment>
              <narrative>Numerator: 12130; Denominator: 26634.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="53.32">
            <comment>
              <narrative>Numerator: 14200.6; Denominator: 26634.16.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="53.32">
            <comment>
              <narrative>Numerator: 14200.6; Denominator: 26634.16.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people who inject drugs that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of people who inject drugs that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 412; Denominator: 3884.59; Percentage: 10.61%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15-19" />
          <comment>
            <narrative>Numerator: 17; Denominator: 412; Percentage: 4.13%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15-19" />
          <comment>
            <narrative>Numerator: 17; Denominator: 412; Percentage: 4.13%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="20-24" />
          <comment>
            <narrative>Numerator: 114; Denominator: 412; Percentage: 27.67%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="20-24" />
          <comment>
            <narrative>Numerator: 114; Denominator: 412; Percentage: 27.67%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 281; Denominator: 412; Percentage: 68.2%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 281; Denominator: 412; Percentage: 68.2%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 22; Denominator: 412; Percentage: 5.34%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 22; Denominator: 412; Percentage: 5.34%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 390; Denominator: 412; Percentage: 94.66%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 390; Denominator: 412; Percentage: 94.66%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 373.4; Denominator: 4497; Percentage: 8.3%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2216; Denominator: 4121; Percentage: 53.77%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 364.33; Denominator: 4497; Percentage: 8.1%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 373.35; Denominator: 4497; Percentage: 8.3%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2216; Denominator: 4121; Percentage: 53.77%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15-19" />
            <comment>
              <narrative>Numerator: 105.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="20-24" />
            <comment>
              <narrative>Numerator: 505.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 1606.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 51.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 1534.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 423.7; Denominator: 4497; Percentage: 9.4%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1178; Denominator: 4497; Percentage: 26.2%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 423.7; Denominator: 4497; Percentage: 9.42%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 423.7; Denominator: 4497; Percentage: 9.42%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1178; Denominator: 4497; Percentage: 26.2%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15-19" />
            <comment>
              <narrative>Numerator: 80.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="20-24" />
            <comment>
              <narrative>Numerator: 305.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 793.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 73.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 1105.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 476.9; Denominator: 4497; Percentage: 10.6%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 476.9; Denominator: 4497; Percentage: 10.6%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of sex workers that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of sex workers that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 37141; Denominator: 74263.95; Percentage: 50.01%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15-19" />
          <comment>
            <narrative>Numerator: 4601; Denominator: 37141; Percentage: 12.39%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15-19" />
          <comment>
            <narrative>Numerator: 4601; Denominator: 37141; Percentage: 12.39%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="20-24" />
          <comment>
            <narrative>Numerator: 11991; Denominator: 37141; Percentage: 32.29%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="20-24" />
          <comment>
            <narrative>Numerator: 11991; Denominator: 37141; Percentage: 32.29%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 20532; Denominator: 37141; Percentage: 55.28%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 20532; Denominator: 37141; Percentage: 55.28%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 37053; Denominator: 37141; Percentage: 99.76%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 37053; Denominator: 37141; Percentage: 99.76%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 88; Denominator: 37141; Percentage: 0.24%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 88; Denominator: 37141; Percentage: 0.24%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 51558.6; Denominator: 87385; Percentage: 59%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 89895; Denominator: 78787; Percentage: 114.1%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 51558.64; Denominator: 87385; Percentage: 59%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 51558.64; Denominator: 87385; Percentage: 59%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 89895; Denominator: 78787; Percentage: 114.1%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15-19" />
            <comment>
              <narrative>Numerator: 11064.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="20-24" />
            <comment>
              <narrative>Numerator: 30496.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 48308.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 89805.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 90.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 56957.32; Denominator: 87385; Percentage: 65.18%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 56957.3; Denominator: 87385; Percentage: 65.2%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 56254; Denominator: 87385; Percentage: 64.37%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 56957.32; Denominator: 87385; Percentage: 65.18%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 56254; Denominator: 87385; Percentage: 64.37%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15-19" />
            <comment>
              <narrative>Numerator: 7591.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="20-24" />
            <comment>
              <narrative>Numerator: 20435.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 28202.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 56254.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 67755.57; Denominator: 87385; Percentage: 77.54%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 67755.57; Denominator: 87385; Percentage: 77.54%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of at-risk adolescent girls and young women who received any PrEP product at least once during the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: Prevention package for adolescent girls and young women (AGYW) and male sexual partners in high HIV incidence settings.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of at-risk adolescent girls and young women who received any PrEP product at least once during the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="191" />
        <baseline year="2022" iso-date="2022-12-31" value="2251">
          <dimension name="Age" value="15-19" />
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="2251">
          <dimension name="Age" value="15-19" />
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="5240">
          <dimension name="Age" value="20-24" />
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="5240">
          <dimension name="Age" value="20-24" />
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="517.5" />
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="1552.5" />
          <actual value="1464" />
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="1035" />
          <actual value="1364" />
          <actual value="659">
            <dimension name="Age" value="15-19" />
          </actual>
          <actual value="805">
            <dimension name="Age" value="20-24" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="2126.2" />
          <actual value="1186" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="1063.1" />
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="1063.1" />
          <actual value="830" />
          <actual value="459">
            <dimension name="Age" value="15-19" />
          </actual>
          <actual value="718">
            <dimension name="Age" value="20-24" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="1095" />
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="1095" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of at-risk adolescent girls and young women reached with HIV prevention programs</narrative>
      </title>
      <description>
        <narrative>Module: Prevention package for adolescent girls and young women (AGYW) and male sexual partners in high HIV incidence settings.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of at-risk adolescent girls and young women reached with HIV prevention programs</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - special.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="30.76">
          <comment>
            <narrative>Numerator: 30000; Denominator: 97520.56.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="46.34">
          <dimension name="Age" value="15-19" />
          <comment>
            <narrative>Numerator: 13901.5; Denominator: 30000.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="46.34">
          <dimension name="Age" value="15-19" />
          <comment>
            <narrative>Numerator: 13901.5; Denominator: 30000.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="39.01">
          <dimension name="Age" value="20-24" />
          <comment>
            <narrative>Numerator: 11704; Denominator: 30000.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="39.01">
          <dimension name="Age" value="20-24" />
          <comment>
            <narrative>Numerator: 11704; Denominator: 30000.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="8.33">
            <comment>
              <narrative>Numerator: 10350; Denominator: 124202.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="25">
            <comment>
              <narrative>Numerator: 31050; Denominator: 124202.</narrative>
            </comment>
          </target>
          <actual value="33.73">
            <comment>
              <narrative>Numerator: 41891; Denominator: 124202.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="16.67">
            <comment>
              <narrative>Numerator: 20700; Denominator: 124202.</narrative>
            </comment>
          </target>
          <actual value="29.49">
            <comment>
              <narrative>Numerator: 36633; Denominator: 124202.</narrative>
            </comment>
          </actual>
          <actual value="44.34">
            <dimension name="Age" value="15-19" />
            <comment>
              <narrative>Numerator: 18432; Denominator: 41566.</narrative>
            </comment>
          </actual>
          <actual value="50.51">
            <dimension name="Age" value="20-24" />
            <comment>
              <narrative>Numerator: 20995; Denominator: 41566.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="16.67">
            <comment>
              <narrative>Numerator: 21262; Denominator: 127571.23.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="33.3">
            <comment>
              <narrative>Numerator: 42524; Denominator: 127571.2.</narrative>
            </comment>
          </target>
          <actual value="34.24">
            <comment>
              <narrative>Numerator: 43674; Denominator: 127571.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="16.67">
            <comment>
              <narrative>Numerator: 21262; Denominator: 127571.23.</narrative>
            </comment>
          </target>
          <actual value="17.77">
            <comment>
              <narrative>Numerator: 22674; Denominator: 127571.</narrative>
            </comment>
          </actual>
          <actual value="44.15">
            <dimension name="Age" value="15-19" />
            <comment>
              <narrative>Numerator: 19283; Denominator: 43674.</narrative>
            </comment>
          </actual>
          <actual value="53.04">
            <dimension name="Age" value="20-24" />
            <comment>
              <narrative>Numerator: 23166; Denominator: 43674.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="16.67">
            <comment>
              <narrative>Numerator: 21900; Denominator: 131398.37.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="16.67">
            <comment>
              <narrative>Numerator: 21900; Denominator: 131398.37.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>KP-1e - Other1: Number of other vulnerable populations (OVP)  who received any PrEP product at least once during the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: Prevention package for other vulnerable populations (OVP).</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>KP-1e - Other1: Number of other vulnerable populations (OVP)  who received any PrEP product at least once during the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="2191" />
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="4696.4" />
          <actual value="3983" />
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="2348.2" />
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="2348.2" />
          <actual value="3084" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="5482.4" />
          <actual value="5647" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="2741.2" />
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="2741.2" />
          <actual value="1395" />
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="2989.6" />
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="2989.6" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of other vulnerable people reached with HIV prevention programs</narrative>
      </title>
      <description>
        <narrative>Module: Prevention package for other vulnerable populations (OVP).</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of other vulnerable people reached with HIV prevention programs</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 10664; Denominator: 25251.18; Percentage: 42.23%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15-19" />
          <comment>
            <narrative>Numerator: 988.5; Denominator: 10664; Percentage: 9.27%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15-19" />
          <comment>
            <narrative>Numerator: 988.5; Denominator: 10664; Percentage: 9.27%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="20-24" />
          <comment>
            <narrative>Numerator: 3859; Denominator: 10664; Percentage: 36.19%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="20-24" />
          <comment>
            <narrative>Numerator: 3859; Denominator: 10664; Percentage: 36.19%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 5812; Denominator: 10664; Percentage: 54.5%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 5812; Denominator: 10664; Percentage: 54.5%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 11741; Denominator: 27814.98; Percentage: 42.21%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 11741; Denominator: 27815; Percentage: 42.2%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 16362; Denominator: 27815; Percentage: 58.82%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 11741; Denominator: 27814.98; Percentage: 42.21%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 16362; Denominator: 27815; Percentage: 58.82%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15-19" />
            <comment>
              <narrative>Numerator: 1324.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="20-24" />
            <comment>
              <narrative>Numerator: 4766.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 10272.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 13706; Denominator: 27814.98; Percentage: 49.28%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 13706; Denominator: 27815; Percentage: 49.3%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 13490; Denominator: 27815; Percentage: 48.5%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 13706; Denominator: 27814.98; Percentage: 49.28%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 13490; Denominator: 27815; Percentage: 48.5%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15-19" />
            <comment>
              <narrative>Numerator: 1323.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="20-24" />
            <comment>
              <narrative>Numerator: 4567.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 7598.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 14948; Denominator: 27814.98; Percentage: 53.74%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 14948; Denominator: 27814.98; Percentage: 53.74%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people who inject drugs reached with HIV prevention programs</narrative>
      </title>
      <description>
        <narrative>Module: Prevention package for people who use drugs (PUD) and their sexual partners.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of people who inject drugs reached with HIV prevention programs</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 404; Denominator: 4238.84; Percentage: 9.53%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15-19" />
          <comment>
            <narrative>Numerator: 17; Denominator: 404; Percentage: 4.21%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15-19" />
          <comment>
            <narrative>Numerator: 17; Denominator: 404; Percentage: 4.21%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="20-24" />
          <comment>
            <narrative>Numerator: 113; Denominator: 404; Percentage: 27.97%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="20-24" />
          <comment>
            <narrative>Numerator: 113; Denominator: 404; Percentage: 27.97%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 274; Denominator: 404; Percentage: 67.82%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 274; Denominator: 404; Percentage: 67.82%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 23; Denominator: 404; Percentage: 5.69%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 23; Denominator: 404; Percentage: 5.69%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 381; Denominator: 404; Percentage: 94.31%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 381; Denominator: 404; Percentage: 94.31%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 383.51; Denominator: 4496.99; Percentage: 8.53%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 393; Denominator: 4497; Percentage: 8.7%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2183; Denominator: 4497; Percentage: 48.54%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 393; Denominator: 4496.99; Percentage: 8.74%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2183; Denominator: 4497; Percentage: 48.54%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15-19" />
            <comment>
              <narrative>Numerator: 100.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="20-24" />
            <comment>
              <narrative>Numerator: 482.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 1601.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 69.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 2043.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 446; Denominator: 4497; Percentage: 9.9%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1288; Denominator: 4497; Percentage: 28.64%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 446; Denominator: 4496.99; Percentage: 9.92%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 446; Denominator: 4496.99; Percentage: 9.92%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1288; Denominator: 4497; Percentage: 28.64%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15-19" />
            <comment>
              <narrative>Numerator: 90.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="20-24" />
            <comment>
              <narrative>Numerator: 326.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 872.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 78.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 1210.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 502; Denominator: 4496.99; Percentage: 11.16%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 502; Denominator: 4496.99; Percentage: 11.16%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of sex workers who received any PrEP product at least once during the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: Prevention package for sex workers, their clients and other sexual partners.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of sex workers who received any PrEP product at least once during the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 1940.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15-19" />
          <comment>
            <narrative>Numerator: 27; Denominator: 1940; Percentage: 1.39%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15-19" />
          <comment>
            <narrative>Numerator: 27; Denominator: 1940; Percentage: 1.39%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="20-24" />
          <comment>
            <narrative>Numerator: 149; Denominator: 1940; Percentage: 7.68%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="20-24" />
          <comment>
            <narrative>Numerator: 149; Denominator: 1940; Percentage: 7.68%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 1764; Denominator: 1940; Percentage: 90.93%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 1764; Denominator: 1940; Percentage: 90.93%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1940; Denominator: 1940; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1940; Denominator: 1940; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 0; Denominator: 1940; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 0; Denominator: 1940; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="PrEP product" value="Oral PrEP" />
          <comment>
            <narrative>Numerator: 1940; Denominator: 1940; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="PrEP product" value="Oral PrEP" />
          <comment>
            <narrative>Numerator: 1940; Denominator: 1940; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 15783.2.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 9233.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 7891.63.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 7891.63.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 8079.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15-19" />
            <comment>
              <narrative>Numerator: 1164.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="20-24" />
            <comment>
              <narrative>Numerator: 3054.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 5015.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 8079.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 29.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="PrEP product" value="Oral PrEP" />
            <comment>
              <narrative>Numerator: 9233.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 17436.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 10695.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 8717.96.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 8717.96.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1376.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15-19" />
            <comment>
              <narrative>Numerator: 1595.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="20-24" />
            <comment>
              <narrative>Numerator: 3797.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 5301.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 10695.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="PrEP product" value="Oral PrEP" />
            <comment>
              <narrative>Numerator: 10569.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 10370.75.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 10370.75.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of sex workers reached with HIV prevention programs</narrative>
      </title>
      <description>
        <narrative>Module: Prevention package for sex workers, their clients and other sexual partners.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of sex workers reached with HIV prevention programs</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 37800; Denominator: 82368.54; Percentage: 45.89%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15-19" />
          <comment>
            <narrative>Numerator: 4703; Denominator: 37800; Percentage: 12.44%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15-19" />
          <comment>
            <narrative>Numerator: 4703; Denominator: 37800; Percentage: 12.44%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="20-24" />
          <comment>
            <narrative>Numerator: 12225; Denominator: 37800; Percentage: 32.34%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="20-24" />
          <comment>
            <narrative>Numerator: 12225; Denominator: 37800; Percentage: 32.34%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 19186; Denominator: 37800; Percentage: 50.76%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 19186; Denominator: 37800; Percentage: 50.76%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 37711; Denominator: 37800; Percentage: 99.76%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 37711; Denominator: 37800; Percentage: 99.76%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 86; Denominator: 37800; Percentage: 0.23%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 86; Denominator: 37800; Percentage: 0.23%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 52610.86; Denominator: 87384.78; Percentage: 60.21%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 52610.9; Denominator: 87384.8; Percentage: 60.2%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 90893; Denominator: 87385; Percentage: 104.01%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 52610.86; Denominator: 87384.78; Percentage: 60.21%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 90893; Denominator: 87385; Percentage: 104.01%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15-19" />
            <comment>
              <narrative>Numerator: 11087.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="20-24" />
            <comment>
              <narrative>Numerator: 30701.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 49078.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 90795.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 98.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 58119.7; Denominator: 87384.8; Percentage: 66.5%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 59359; Denominator: 87385; Percentage: 67.93%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 58119.72; Denominator: 87384.78; Percentage: 66.51%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 58119.72; Denominator: 87384.78; Percentage: 66.51%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 59359; Denominator: 87385; Percentage: 67.93%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15-19" />
            <comment>
              <narrative>Numerator: 7933.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="20-24" />
            <comment>
              <narrative>Numerator: 21431.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 29969.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 59359.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 69138.34; Denominator: 87384.78; Percentage: 79.12%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 69138.34; Denominator: 87384.78; Percentage: 79.12%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of community organizations that received a pre-defined package of training</narrative>
      </title>
      <description>
        <narrative>Module: RSSH: Community systems strengthening.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of community organizations that received a pre-defined package of training</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 230; Denominator: 219; Percentage: 105.02%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Organization type" value="Community-based organizations" />
          <comment>
            <narrative>Numerator: 200; Denominator: 230; Percentage: 86.96%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Organization type" value="Community-based organizations" />
          <comment>
            <narrative>Numerator: 200; Denominator: 230; Percentage: 86.96%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Organization type" value="Community-led organizations" />
          <comment>
            <narrative>Numerator: 30; Denominator: 230; Percentage: 13.04%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Organization type" value="Community-led organizations" />
          <comment>
            <narrative>Numerator: 30; Denominator: 230; Percentage: 13.04%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Community-led organization type" value="KP-led (HIV)" />
          <comment>
            <narrative>Numerator: 25; Denominator: 230; Percentage: 10.87%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Community-led organization type" value="KP-led (HIV)" />
          <comment>
            <narrative>Numerator: 25; Denominator: 230; Percentage: 10.87%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Community-led organization type" value="KVP-led (TB)" />
          <comment>
            <narrative>Numerator: 3; Denominator: 210; Percentage: 1.43%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Community-led organization type" value="KVP-led (TB)" />
          <comment>
            <narrative>Numerator: 3; Denominator: 210; Percentage: 1.43%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 69.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 113.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 69.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 113.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Organization type" value="Community-based organizations" />
            <comment>
              <narrative>Numerator: 86; Denominator: 113; Percentage: 76.11%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Organization type" value="Community-led organizations" />
            <comment>
              <narrative>Numerator: 25; Denominator: 113; Percentage: 22.12%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Community-led organization type" value="KP-led (HIV)" />
            <comment>
              <narrative>Numerator: 22; Denominator: 113; Percentage: 19.47%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Community-led organization type" value="KVP-led (TB)" />
            <comment>
              <narrative>Numerator: 1; Denominator: 113; Percentage: 0.88%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 137.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 274.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 254.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 137.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 130.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Organization type" value="Community-based organizations" />
            <comment>
              <narrative>Numerator: 107; Denominator: 130; Percentage: 82.31%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Organization type" value="Community-led organizations" />
            <comment>
              <narrative>Numerator: 23; Denominator: 130; Percentage: 17.69%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Community-led organization type" value="KP-led (HIV)" />
            <comment>
              <narrative>Numerator: 16; Denominator: 130; Percentage: 12.31%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Community-led organization type" value="KVP-led (TB)" />
            <comment>
              <narrative>Numerator: 16; Denominator: 130; Percentage: 12.31%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 0; Denominator: 0.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 0; Denominator: 0.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of health service delivery sites with a community-led monitoring mechanism in place</narrative>
      </title>
      <description>
        <narrative>Module: RSSH: Community systems strengthening.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of health service delivery sites with a community-led monitoring mechanism in place</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2021" iso-date="2021-12-31">
          <comment>
            <narrative>Numerator: 320; Denominator: 320; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 200; Denominator: 400; Percentage: 50%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 0; Denominator: 0.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 0; Denominator: 0.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 200; Denominator: 400; Percentage: 50%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 0; Denominator: 0.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 400; Denominator: 400; Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 277; Denominator: 400; Percentage: 69.25%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 300; Denominator: 400; Percentage: 75%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 400; Denominator: 400; Percentage: 100%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 277; Denominator: 400; Percentage: 69.25%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 400; Denominator: 400; Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 400; Denominator: 400; Percentage: 100%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Contact investigation coverage: Proportion of contacts of people with bacteriologically confirmed TB evaluated for TB among those eligible</narrative>
      </title>
      <description>
        <narrative>Module: TB/DR-TB Prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Contact investigation coverage: Proportion of contacts of people with bacteriologically confirmed TB evaluated for TB among those eligible</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="84.05">
          <comment>
            <narrative>Numerator: 368389; Denominator: 438319.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="86">
            <comment>
              <narrative>Numerator: 305207; Denominator: 354891.</narrative>
            </comment>
          </target>
          <actual value="90.05">
            <comment>
              <narrative>Numerator: 419574; Denominator: 465913.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="86">
            <comment>
              <narrative>Numerator: 152603.5; Denominator: 177445.5.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="86">
            <comment>
              <narrative>Numerator: 152603.5; Denominator: 177445.5.</narrative>
            </comment>
          </target>
          <actual value="91.62">
            <comment>
              <narrative>Numerator: 214819; Denominator: 234480.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 346145; Denominator: 384606.</narrative>
            </comment>
          </target>
          <actual value="93.83">
            <comment>
              <narrative>Numerator: 307271; Denominator: 327483.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 173072.5; Denominator: 192303.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 173072.5; Denominator: 192303.</narrative>
            </comment>
          </target>
          <actual value="96.69">
            <comment>
              <narrative>Numerator: 141129; Denominator: 145955.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="95">
            <comment>
              <narrative>Numerator: 187984.5; Denominator: 197878.5.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="95">
            <comment>
              <narrative>Numerator: 187984.5; Denominator: 197878.5.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of people in contact with TB patients who began preventive therapy</narrative>
      </title>
      <description>
        <narrative>Module: TB/DR-TB Prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of people in contact with TB patients who began preventive therapy</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="133212" />
        <baseline year="2022" iso-date="2022-12-31" value="31149">
          <dimension name="Age" value="&lt;5" />
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="31149">
          <dimension name="Age" value="&lt;5" />
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="121846" />
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="243692" />
          <actual value="268356" />
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="121846" />
          <actual value="138283" />
          <actual value="50717">
            <dimension name="Age" value="&lt;5" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="295982" />
          <actual value="185911" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="147991" />
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="147991" />
          <actual value="85329" />
          <actual value="8848">
            <dimension name="Age" value="&lt;5" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="167127" />
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="167127" />
        </period>
      </indicator>
    </result>
  </iati-activity>
</iati-activities>